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	Riassunto 
La conversione dell’anidride carbonica (CO2) in bicarbonato (HCO3-) e protoni 
(H+) è una reazione fisiologicamente rilevante in tutti gli organismi viventi. La 
reazione CO2 + H2O ⇋ HCO3- + H+ non catalizzata è lenta a pH fisiologico e quindi, 
nei sistemi biologici, è accelerata da catalizzatori enzimatici, noti con il nome di 
anidrasi carboniche (CA, EC 4.2.1.1). Le CA sono state trovate in quasi tutti i tessuti 
di mammiferi e tipi cellulari, e sono coinvolte nel trasporto della CO2 e in altri 
importanti processi fisiologici. 
Nella presente tesi è riportato lo studio sui profili d’inibizione delle CA 
identificate nel genoma di organismi patogeni per l’uomo, quali Vibrio cholerae, 
Plasmodium falciparum, Porphyromonas gingivalis e Malassezia globosa. 
Le CA codificate dagli organismi suddetti sono state caratterizzate 
biochimicamente e i loro profili d’inibizione, ottenuti utilizzando gli inibitori classici 
delle CA, come le sulfonamidi e gli anioni, sono stati ampiamente esaminati. Tale 
studio ha dato un grande contributo alla ricerca di potenziali antibiotici con un nuovo 
meccanismo d'azione. Inoltre, la presente tesi ha contribuito alla scoperta di a) una 
nuova famiglia genica di CA, indicata con la lettera greca η; b) alla messa a punto di 
una nuova tecnica, denominata protonografia, utile per l'identificazione dell’attività 
delle CA su gel di poliacrilamide; e c) all’analisi filogenetica delle CA di classe α, β 
e γ identificate nel genoma dei batteri Gram-positivi e Gram-negativi. 
 
  
	Abstract 
The conversion of carbon dioxide (CO2) to bicarbonate (HCO3-) and protons 
(H+) is a physiologically relevant reaction in all life kingdoms. The uncatalyzed 
hydration-dehydration reaction CO2 + H2O ⇋ HCO3- + H+ is slow at physiological 
pH and thus, in biological systems, the reaction is accelerated by enzymatic catalysts, 
called carbonic anhydrases (CAs, EC 4.2.1.1). CA isozymes have been found in 
virtually all mammalian tissues and cell types, where they function in CO2 transport 
and other physiological processes.  
In the present thesis, it has been carried out a wide study concerning the 
inhibition profiles of CAs identified in the genome of pathogens causing disease in 
humans, such as Vibrio cholerae, Plasmodium falciparum, Porphyromonas 
gingivalis and Malassezia globosa 
CAs from the pathogens aforementioned were biochemically characterized and 
an extensive inhibition profile was carried out using the classical CAs inhibitors such 
as sulfonamides and anions. These studies have contributed to the search of 
antibiotics with a novel mechanism of action. Additionally, the present thesis has 
contributed to the discovery of the η-CA, a new genetic families of CAs; to the 
introduction of a new technique, named protonography, useful for the identification 
of CA activity on a polyacrylamide gel; and to the phylogenetic analysis of the α-, β- 
and γ-CAs identified in the genome of the Gram-positive and Gram-negative 
bacteria.
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Chapter 1. Introduction 
1.1 Carbonic anhydrases 
Carbonic anhydrases (CAs, EC 4.2.1.1) are ubiquitous metalloenzymes present 
in all life kingdoms: Archaea, Bacteria and Eucarya. Formed by the convergent 
evolution of at least seven families of genes (α, β, γ, δ, ζ, η and θ) (Supuran., 2008 ; 
Sae Kikutania., et al., 2016 ). CAs have been identified for the first time in red blood 
cells of bovine (Meldrum N.U. & Roughton F.J. 1933). Later, they have been found 
in all mammalian tissues, but also in plants, algae and bacteria. CAs owe their 
ubiquity to the ability to catalyze a simple but physiologically relevant reaction for 
living being (Capasso C. & Supuran C.T. 2015), i.e. the reversible hydration of 
carbon dioxide with the formation of bicarbonate and protons according to the 
following formula: 
CO2+H2O ⇋ HCO3- + H+ 
The reaction of hydration of CO2 consists of four reactions: 
1) CO2(g) ⇋ CO2(aq)  reaction of dissolution in aqueous phase 
2) CO2(aq) + H2O ⇋ H2CO3 hydration reaction (carbonic acid production) 
3) H2CO3 ⇋ HCO3- + H+ ionization reaction (bicarbonate production) 
4) HCO3- ⇋ CO32- + H+ dissociation reaction (carbonate formation) 
 
In physiological conditions and in the absence of the catalyst, the reaction 2 is 
the limiting step of the entire process and, the kcat assumes a value of 1.5 x 10-1 s-1 
(Edsall J.T. 1968). The carbonic anhydrase, able to convert a million molecules of 
CO2 per second, increases the value of the kcat from 10-1 s-1 to 105 s-1. CAs are among 
the fastest enzymes known. 
1.2 Physiological role of CAs 
CAs in mammals are involved in breathing and transport of carbon dioxide and 
bicarbonate in tissues and lungs, in the homeostasis of pH and CO2 in biosynthetic 
reactions such as gluconeogenesis, lipogenesis, ureagenesis, where the bicarbonate 
acts as a substrate for the reaction of carboxylation, bone resorption, calcification and 
tumorigenicity (Supuran C.T., et al. 2015). However, in microorganisms, in addition 
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to the transport of carbon dioxide bicarbonate and its supply of for biosynthetic 
reactions, carbonic anhydrases are involved in: a) carbon fixation for the 
photosynthetic process; b) metabolism of xenobiotics (degradation of the cyanate in 
E. coli); c) pH regulation; d) survival of the pathogen within the host organism; d) 
synthesis of purine and pyrimidine as in the protozoan Plasmodium falciparum 
(Supuran C.T. & Capasso C. 2014).  
In mammals, at the level of the peripheral tissue, due to the pressure gradient, the 
carbon dioxide, produced by the aerobic metabolism, leave the cells and enter the 
blood, dissolving in the plasma (reaction 1). From here, about 90% of the carbon 
dioxide enters the red blood cells and, thanks to the action of carbonic anhydrase 
reacts with water, forming carbonic acid (reaction 2) which in turn dissociates into 
bicarbonate ion and hydrogen ion (reaction 3). Bicarbonate leaves the red blood cell 
by a protein antiporter. This transport process, defined exchange of chlorides, 
exchanges one HCO3- ion with a Cl- ion. The exchange takes place in the ratio of 1: 1 
by maintaining electrical neutrality and, consequently, the membrane potential of the 
cell is not changed. The ion HCO3- is converted to carbonate and protons H+ 
(reaction 4), which are linked by hemoglobin, which acts as a buffer (Boron W.F. 
2010). At the alveolar level, however, the CO2 concentration is lower than that in the 
peripheral tissues, while there is a higher concentration of bicarbonate that is pumped 
inside the red cell. Here, by the action of the reverse reaction catalyzed by the CAs, 
the bicarbonate is converted into carbonic acid, which will give water and carbon 
dioxide. The CO2 thus produced, is released into the blood and, passing by diffusion 
through the walls of the alveolus, is exhaled. The direction of the reaction, therefore, 
depends on the concentration of CO2: if this is low (as in the lungs), the acid is 
dissociated, with release of carbon dioxide; If this is high, dioxide binds water to 
form carbonates that are transported by the blood to the lungs (Boron W.F. 2010). 
1.3 CA classes 
 Until now were identified 7 distinct gene families of CAs (Supuran C.T. & 
Capasso C. 2014): 
• α-CA: invertebrates, fungi, protozoa, corals, algae, cytoplasm of green plants 
and some bacteria 
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• β-CA: mainly in bacteria, algae and plant chloroplasts mono and dicots, many 
fungi and Archaea 
• γ-CA: mainly in Archaea, some bacteria and plants 
• δ-CA: marine phytoplankton (diatoms) 
• η-CA: protozoa Plasmodium falciparum 
• θ-CA: marine diatoms Phaeodactylum tricornutum 
 
The α-, β-, δ-, η- and, perhaps θ-CAs use Zn(II) ions at the active site, the γ-CAs 
are probably Fe(II) enzymes (but they are active also with bound Zn(II) or Co(II) 
ions), whereas the ζ-class CAs are cambialistic enzymes, active both with Cd(II) or 
Zn(II) bounded within the active site in order to perform the physiologic reaction 
catalysis.	(Vullo D., et al. 2014; Del Prete S., et al. 2014; Capasso C. & Supuran C.T. 
Expert Opin. Ther. Pat., 23 2013).  
In mammals, there are only α-CAs, of which 16 isoforms were identified, 
marked with Roman numbers (Supuran C.T. et al., 2008; Supuran C.T., et al. 2004; 
Scozzafava A., et al. 2000; Winum J.Y. et al. 2006; Saczewski F., et al. 2006; De 
Simone G., et al. 2006). These isoenzymes can be distinguished according to the 
different tissue distribution, subcellular localization and catalytic activity (Supuran 
C.T. 2008). In particular, we divide the mammalian α-CAs in: 
• Cytosolic (isoenzymes I, II, III, IV, VIII) 
• Mitochondrial (isoenzymes VA, VB) 
• Membrane-bound (isoenzymes IV, IX, XII, XIV, XV) 
• Secreted in saliva (isoenzyme VI) 
• Catalytically inactive isoforms (CARP VIII, X and XI) 
1.4 Catalytic mechanism 
In Figure 1 is reported the alignment of the α-CA amino acid sequences: four 
human isoforms (hCA I, hCA II, hCAVA and hCAVI) and two bacterial CAs 
represented by SspCA, identified in the genome of the thermophilic bacterium 
Sulfurihydrogenibium yellowstonense and, VchCA present in the genome of the 
mesophilic bacterium Vibrio cholerae.  
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Figure 1. Multialignment of the amino acid sequences of four human and bacterial CAs 
was realized with the ClustalW program, version 2.1. In red shows the amino acid residues 
of the catalytic triad, green residues "gate-keeper" and the blue "proton shuttle residual". It 
was used the numbering system hCA. 
The amino acid residues involved in the catalytic mechanism of the α-CAs, 
which consists of four steps, are colored in the alignment. In the first step zinc ion, 
present in the catalytic site of the enzyme, is bound to the hydroxyl ion (Figure 2, 
Panel A). This configuration corresponds to the active form of the enzyme. The 
substrate CO2 is bound in a hydrophobic pocket near the Zn(II) ion, defined among 
others by residues Val121, Val143 and Leu198 (in the human isoform hCA II). 
Orientated in a favorable position for the nucleophilic attack of the enzyme, CO2 is 
transformed into bicarbonate. (Figure 2, Panel B). The bicarbonate ion is then 
displaced by a water molecule and released in solution (Figure 2, Panel C). In this 
way, the water molecule coordinated to the zinc, generates the acidic form of the 
enzyme, which is catalytically inactive (Figure 2, Panel D). The catalytically active 
form of the enzyme is regenerated through the reaction of transfer of a proton from 
the active site of the enzyme to the environment (Figure 2, Panel A). The speed of 
this transfer is highly dependent on the residue His64 known as "proton shuttle 
residue" (Supuran C.T. 2008)(see Figure 2).  
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Figure 2. Schematic representation of the catalytic mechanism of a α-CAs. 
In the catalytically very active isoenzymes, such as hCAII hCAIV, hCAVII and 
hCAIX, the transfer process of the proton from the enzyme to the environment is 
assisted by His64 positioned at the entrance of the active site and, by a cluster of 
histidine (His4, His3, His17, His15 and His10), which protrude from the edge of the 
active site of the enzyme on the surface, ensuring efficient removal of the proton by 
the enzyme (Figure 3). This explains why they are the most active known CAs 
(kcat/KM about 1.5 x 108 M-1 s-1) (Supuran C.T. 2008). In other CA, such as the hCA 
III, the catalytic efficiency is lower because the residue His64 was absent and in 
position 198, a phenylalanine replaces the residue of leucine causing a steric 
hindrance near the catalytic site (Chegwidden W.R., Carter N.D., Edwards Y.H. 
2000). α-CAs are also able to catalyze the hydrolysis of esters/thioesters, (for 
example 4-nitrophenyl acetate (4-NpA) hydrolysis, as well as other hydrolytic 
reactions); while no esterase activity was detected so far for enzymes belonging to 
the other five CA genetic families. (Del Prete S, et al. 2014; Guzel O., et al. 2010). 
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Figure 3. Structure of the active site of hCAII. 
Are also known catalytically inactive isoforms of α-CAs, indicated as CARPs 
(Carbonic Anhydrase Related Proteins). The CARPs occur independently or as 
domains of other proteins in animals (both vertebrates and invertebrates) and viruses. 
Although these proteins show a high degree of homology with the other known CA 
isoforms (hCA I–VII, IX, and XII–XIV), they distinguish themselves from the 
catalytically active CAs by a salient feature: they lack one, two or all three zinc 
ligands from the enzyme active site, that is, His94, 96 and 119 (the hCA I numbering 
system). The phylogenetic analysis shows that these proteins are highly conserved 
across the species. The three CARPs in vertebrates are known as CARP VIII, X and 
XI. Most of these CARPs are predominantly expressed in central nervous system. 
Among the three vertebrate CA isoforms, CARP VIII is functionally associated with 
motor coordination in human, mouse and zebrafish and certain types of cancers in 
humans. Vertebrate expression studies show that CARP X is exclusively expressed 
in the brain. CARP XI is only found in tetrapods and is highly expressed in the 
central nervous system (CNS) of humans and mice and is also associated with 
several cancers. CARP VIII has been shown to coordinate the function of other 
proteins by protein-protein interaction, and viral CARPs participate in attachment to 
host cells, but the precise biological function of CARP X and XI is still unknown. 
(Aspatwar A., et al. 2014).  
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1.5 Characteristics of the CA classes 
1.5.1 α-CAs 
The most studied class of carbonic anhydrase, as well as that of which there are 
the largest number of three-dimensional structures, is the α-class. They contain the 
zinc ion (Zn2+) in their active site coordinated by three histidine residues (His94, 
His96 and His119) and a water molecule/hydroxide ion (see Figure 4). Available α-
CA structures, including most isoforms of human CA (hCA), reveal that the zinc ion 
is located in the pocket of the active site deep 15 Å (Figure 4). 
 
 
 
 
 
 
 
Figure 4. 3D structure and a particular of the active site of the human isoform II 
(hCAII). Legend: Orange sphere is the zinc ion; His 94, His 96, His119 are the amino acid 
residues of the catalytic triad; Thr199 and Glu106 are gate-keeping residues.  
The water molecule bound to the zinc forms a hydrogen bond with the hydroxyl 
of Thr199, in turn linked to the carboxyl group of Glu106 (Supuran C.T., 2008). 
These interactions increase the nucleophilicity of the water molecule bound to the 
Zn(II) and orient the substrate (CO2) in a favorable position for nucleophilic attack. It 
is interesting to note that the above-mentioned residues, are conserved in all human 
CAs with catalytic activity (Figure 1), with the exception of the human isoform 
hCAVA where the proton shuttle residues is missing. Up to date are available the 
crystallographic structures of α class CAs, such as hCA I, hCA II, hCA III, hCA IV, 
hCA V, hCA IX, hCA XII and hCA XIV (Alterio V., et al. 2012). Interesting, two 
human isoforms hCA IX and XII are associated with cancer and are involved in the 
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pH regulation and progression of the tumor. The α-CA are normally found in 
monomeric form with a molecular weight of approximately 29 kDa, with the 
exception of hCA VI, hCA IX and XII which occur as dimers (Boztas B., et al. 2015; 
Dudutiene V., et al. 2014). The bacterial α-CAs, such as those identified in the 
genome of Sulfurihydrogenibium yellowstonense, S. azorense and Neisseria 
gonorrhoeae, are dimers formed by two identical active monomers. Among the 
various classes of CAs, the α-class are the most active. The reactions catalyzed by α-
CA, as well as the physiological reaction of hydration of CO2 (Supuran C.T. 2008) 
are: hydration of cyanide to carbonic acid (1.1), or of cyanamide to urea (1.2 – 1.3), 
hydration of aldehydes to geminal diol (1.4), hydrolysis of carboxylic or sulphonic 
esters (1.5 – 1.6) in addition to other minor hydrolytic processes (1.7 – 1.9). 
Recently, it has been demonstrated that α-CA possess also the thioesterasic activity 
(1.10) (Tanc M., et al. 2015) (see list below).  
List of reactions catalyzed by α-CAs: 
(1.1) O=C=O+ H2O ⇋ HCO3-+ H+ 
(1.2) O=C=NH + H2O ⇋ H2NCOOH 
(1.3) HN=C=NH + H2O ⇋ H2NCONH2 
(1.4) RCHO + H2O ⇋ RCH(OH)2 
(1.5) RCOOAr + H2O ⇋  RCOOH + ArOH 
(1.6) RSO3Ar + H2O ⇋ RSO3H + ArOH 
(1.7) ArF + H2O ⇋ HF + ArOH  
(1.8) PhCH2OCOCl + H2O ⇋ PhCH2OH + CO2 + HCl 
(1.9) RSO2Cl + H2O ⇋ RSO3H + HCl  
(1.10) PhSO2NHCSSMe ⇋ C6H5SO2NH2 + CH4S +COS 
(Ar = 2,4-dinitrophenyl)  
(R = Me; Ph) 
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1.5.2 β-CAs 
Most of bacteria, Archaea as Methanobacterium thermoautotrophicum, 
chloroplasts of algae and higher plants, contain CA belonging to the β-class (Smith 
K.S. & Ferry J.G. 2000; Smith K.S. & Ferry J.G. 1999; Badger M.R. & Price G.D. 
1994; Nishimori I., et al. 2007). In β-CAs Zn(II) ion is coordinated by two Cys 
residues, a residue of His and the carboxyl group of a residue of Asp (Figure 5 and 
6A). β-CAs identified in chloroplasts, have as fourth ligand a water molecule 
(Mitsuhashi et al. 2000; Smith K.S., et al. 1999; Cronk J.D., et al. 2001; Kimber 
M.S., et al. 2000) (Figure 6B). The residues of the catalytic triade are highly 
conserved (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Multi alignment of amino acid sequences of β-CAs belonging to plants, yeast, 
fungi and bacteria, made with the ClustalW program, version 2.1. It was used the numbering 
system of Pisum sativum. The ligands of Zn (II) are shown in red. Legend: FbiCA_plant, 
Flaveria bidentis, isoform I; VraCA_plant, Vigna radiata; PsaCA_plant, Pisum sativum; 
Can2_fungus; Cryptococcus neoformans; SceCA_yeast, Saccharomyces cerevisiae; 
CalCA_fungus, Candida albicans; HpyCA_bacterium, Helicobacter pylori.  
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Figure 6. Coordination of Zn (II) in the β-CAs. A: Porphyridium purpureum and 
Escherichia coli; B: Pisum sativum and Methanobacterium thermoautotrophicum. 
It has been demonstrated that at a pH of 7.5 or lower, the active site of carbonic 
anhydrase β is "locked", since the carboxyl group of an aspartic acid coordinates the 
zinc ion as a fourth ligand. At pH values higher than 8.3 the enzyme active site is 
converted in an open one, since the aspartate forms a salt bridge with residue Arg46 
(numbering hpβCA) stored in all the carbonic anhydrase from β class (Nishimori I., 
et al., 2007). In this way, the molecule of water/hydroxide ion has the possibility to 
coordinate the metal ion to the completion of its tetrahedral geometry. As a result, 
the catalytic mechanism of β-CAs with the active site "open" is rather similar to the 
enzymes of α class. Respect to the α-class, β-CAs are oligomers formed by two or 
more identical subunits. Generally, β-CAs are dimers, tetramers and octamers. The 
monomeric subunit has a molecular weight of 25-30 kDa and the active form of the 
enzyme requires two subunits to reconstitute the catalytic site. Among the β-classes 
are available the crystal structures of the CA isolated from red alga Porphyridium 
purpureum, from chloroplasts of Pisum sativum, and prokaryotic CAs isolated from 
Escherichia coli and the archaebacterium Methanobacterium thermoautotrophicum 
(Cronk J.D., et al. 2001; Strop P., et al. 2001).  
 
1.5.3 γ-CAs 
The first γ-class carbonic anhydrase identified was isolated from the 
methanogenic archaebacterium Methanosarcina thermophila and is indicated by the 
acronym "Cam" (Smith K.S. & Ferry J.G. 2000; Kisker C., et al. 1996; Iverson T.M., 
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et al., 2000; Innocenti A., et al. 2004; Alber B.E. & Ferry J.G. 1994). Compared with 
the α-CA and β-CA, Cam has a number of characteristics that differentiate it from 
these. In particular, the monomer Cam self-assembles forming an active homo-trimer 
with an approximate molecular weight of 70 kDa (Figure 7).  
 
 
 
 
 
 
 
Figure 7. Tridimensional structure of γ-CA. 
The monomers are indicated in red, yellow and 
green colors.  
The single monomers of the γ-CAs, with molecular weight of about 20 kDa, did not 
show catalytic activity. The active sites are localized at the interface between the 
monomers and the ion Zn(II) is coordinated by three histidine residues each coming 
from a monomer. γ-CA active site assumed a trigonal bi-pyramidal geometry in the 
Cam containing zinc ion, and an octahedral geometry in enzyme binding cobalt. The 
catalytic mechanism is similar to that proposed for the α-CA. At present, the 
mechanism zinc hydroxide, suggested for γ-CA is valid, but it is likely that in the 
active site of the enzyme may also be a balance between trigonal bi-pyramidal and 
tetrahedral metal ion species. The ligands in the active site of the enzyme are in 
contact with the side chain of the residue Glu62, which suggests that this side chain 
can be protonated. In Cam, which has zinc uncomplexed, the side chains of residues 
Glu62 and Glu84 seem to share a proton and the residue Glu84 can be in multiple 
conformations. This suggests that the residue Glu84 performs a function similar to 
that of residue His64 in α-CA (Supuran C.T. 2008). 
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1.5.4 δ- e ζ-CAs 
Unlike δ-CAs, which are widely distributed throughout the marine phytoplankton, 
the ζ-CAs are present only in diatoms. Recently in the marine diatom Thalassiosira 
weissflogii have been identified two CA, TweCA (or TWCA1) and CDCA1, 
belonging respectively to classes δ and ζ (Alterio V., et al. 2012). TweCA is a 27 
kDa protein, probably a monomer, which does not show significant sequence 
similarity with other carbonic anhydrases. It is an example of convergent evolution, 
even if the crystallographic studies show that the active site is similar to that of α-
CA, with zinc ion coordinated by three histidine residues and one water molecule 
(Supuran C.T. 2008). The location of this enzyme in T. weissflogii and other diatoms 
it is not known, although recent studies suggest that TweCA has a cytoplasmic 
localization and catalyzes the reaction of dehydration of HCO3- to CO2, increasing 
the concentration in the cytoplasm (Lee R.B.Y., et al. 2013). 
CDCA1 is a protein belonging to the family of the ζ-CA, is composed of three 
identical subunits named R1, R2, and R3 that form an active enzyme of 69 kDa. 
CDCA1 contains in the catalytic site ion Cd(II), although it is able to operate even 
with the ion Zn(II) (Figure 8). The rapidity of the exchange between the metal ion 
Zn(II) ion and Cd(II) depends on the availability of the metal ions in the marine 
environment. In literature is reported the crystallographic structure of the three 
subunits that comprise it. (Xu Y., et al. 2008).  
 
 
 
 
 
Figure 8. ζ-CA catalytic site. Ion Cd (II) can be replaced 
by Zn (II) without losing the catalytic activity (numbering 
of the R1 subunit of the enzyme of T. weissflogii). 
In the subunit R2, the Cd(II) of the active site it is located in a pocket in the shape of 
funnel, coordinated by residues Cys263, His315, Cys325 and by a molecule of water. 
In the R1 subunit of CDCA1, the Cd(II) has coordination identical to the R2 subunit 
(Figure 8). Since all three subunits have sequence homology rather high, it is 
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possible that the coordination geometry of the metal ion is similar also for the 
subunit R3. Since T. weissflogii grows in a marine habitat characterized by zinc salts 
and cadmium, it was hypothesized that the carbonic anhydrase CDCA1 containing 
cadmium, replace the enzyme TweCA in the mechanism of carbon concentration, 
when the concentration of marine zinc is very low. The mechanism of carbon 
concentration has developed in many species of phytoplankton to compensate for the 
low availability of CO2 present in the water. In fact, carbonic anhydrases have the 
function of increasing the CO2 concentration in proximity of ribulose 1,5-
bisphosphate carboxylase/oxygenase (RuBisCo), the primary enzyme involved in 
carbon fixation, by allowing the enzyme to work efficiently (Xu Y., et al. 2008). 
Therefore, the carbonic anhydrases are key enzymes regarding the acquisition of 
inorganic carbon for photosynthesis in the phytoplankton. 
1.5.5 η-CAs. 
The causative agent of human malaria, Plasmodium falciparum, was one of the 
first protozoa to be investigated for the presence of CAs. The open reading frame of 
the malarial CA enzyme encodes a 600 amino acid polypeptide chain. In 2004, 
Krungkrai and coworkers cloned a truncated form of Plasmodium falciparum CA 
gene (GenBank: AAN35994.2) encoding for an active CA (named PfCA1) with a 
primary structure of 235 amino acid residues (Krungkrai SR., et al, 2004). The 
metalloenzyme showed a good esterase activity with 4-nitrophenylacetate as a 
substrate. The authors observed that the highly conserved α-CA active site residues, 
responsible for binding of the substrate and for catalysis, were present also in PfCA1 
and considered thus the Plasmodium enzyme belonging to the α-CA class (Figure 9).   
 
 
 
 
 
Figure 9. Multialignment of the amino acid sequence of the truncated form 
of the gene encoding for the PfCA1 with the amino acid sequences of the 
human isoforms (hCA I and II).  
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In the present thesis has been showed that PfCA1 is a new CA-class, denominated 
with the Greek letter η-CA (Capasso C. & Supuran C.T., 2015). In fact, the 
alignment of the three-dimensional structures related to PfCA1 and several members 
of the α-CAs, allowed us to reveal the unique characteristics of the η-CA (De Simone 
G., et al. 2015): the metal ion is coordinated by two histidine residues (His94, His96) 
and one residue of glutamine (Glu 119) as described in chapter 7. 
1.5.6 θ-CAs, the last discovered class. 
The θ-CA is a domain of the Cys-Gly-His–rich (CGHR) protein family (Sae 
Kikutania., et al., 2016 )It has been recently targeted into the lumen of the pyrenoid-
penetrating thylakoid of the marine diatom Phaeodactylum tricornutum, where it 
seems to play an essential function in photosynthesis, although its reported that CO2 
hydration activity seems to be very low. Probably, its main physiological function is 
to control the pH gradient across the thylakoid membrane and to supply CO2 to the 
Calvin cycle (Sae Kikutania., et al., 2016). The detection of Zn in purified θ-CA 
strongly suggests that at least three residues of the highly conserved CGHR domain 
amino acid sequence are involved in Zn binding, such as Cys307, Asp309, His349, 
His363, and Cys387. On the basis of putative active-site amino acids, θ-CA is 
dissimilar to α- and δ-CAs and most similar to β- and ζ-CAs, which use cysteine, 
histidine, and sometimes aspartate to coordinate the metal ion. By contrast, the 
recombinant θ-CA exhibited esterase activity in addition to CA activity. Esterase 
activity is well known for α- and δ-CAs, thus, the biochemical properties of this θ-
CA appear to be distinct from other known CAs. 
 
1.6 Inhibitors 
There are two main classes of CA inhibitors (CAIs). The first class comprises the 
inorganic anions complexing metals, the second class includes organic ligands 
represented by the sulfonamides and related bioisosteres (sulfamates, sulfamides, 
hydroxamate and xanthates). Both classes of inhibitors work by coordinating the 
metal ion in the active site of the enzyme or through a replacement mechanism, 
forming tetrahedral adducts, or by an addition mechanism, generating trigonal-bi-
pyramidal adducts (Figure 10) (Supuran C.T. 2008) according the following single 
reactions: 
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A. E-Zn2+ - OH2 + I ó E-Zn2+- OH2(I) (addition)  
Trigonal-bi-pyramidal adduct 
 
B. E-Zn2+ - OH + I ó E-Zn2+ - I + H2O (substitution)  
Tetrahedral adduct 
 
Since the thirties of the last century, it was known that inorganic ions more 
effective in inhibiting the activity of CA were cyanate and thiocyanate ions 
(Meldrum N.U. & Roughton F.J. 1933). Generally, anion inhibitors bind to zinc for 
addition thereby generating the trigonal-bipyramidal adduct (Figure 10A). The 
inorganic inhibitors complexing metals find no application in therapy because of 
their poor selectivity as well as the resulting numerous side effects. Moreover, 
having a reduced size, it is very complicated, if not impossible, to perform an 
optimization of their structure (Supuran C.T. 2008).  
The sulfonamides derivatives even in this case their activity has long been 
known. In 1948, Krebs was the first to recognize its inhibitory action on CAs (Krebs 
HA, 1948) and, as of that date, the CAI entering treatment were dozens, even if, for 
some of these, the activities anti-CAs was not known. (Dogne J.M., et al.  2006; 
Knudsen J.F., et al. 2004; Supuran C.T. 2008). The primary sulfonamides (R-SO2-
NH2) are the classic inhibitors of CA and are used for the past half-century as 
diuretic and anti-glaucoma medications. Recently, they have also been found 
anticonvulsant, anti-obesity, anti-cancer, anti-infection and anti-panic properties, 
(Supuran C.T. et al. 2009; Winum J. et al. 2008; Domsic J.F., et al. 2008; Supuran 
C.T., et al. 2008; De Simone G. et al. 2008; Mincione F., et al.  2009; Krungkrai J. et 
al. 2008).  
                 
    Figure 10. CAs inhibition mechanisms. 
As discussed for the anions inhibitors, the mechanism of action of sulfonamides 
is based on the interaction of the inhibitor with the metal ion (Figure 10). In fact, the 
sulfonamide group, in contact with the acid environment of the catalytic site, loses a 
A B 
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proton and forms a dative bond with the Zn (II) by substitution of the hydroxide ion 
(Figure 10 B). The inhibitor-metal complex is stabilized by two hydrogen bonds 
between the sulfonamide group and the residue of Thr199 (Figure 11).  
 
 
 
 
 
 
Figure 11. Binding of sulphonamidic CAI. 
Some of CAI having significant inhibitory activity, such as sulfonamide 
derivatives used in clinical (acetazolamide, methazolamide, ethoxzolamide, 
dichlorophenamide, dorzolamide and brinzolamide) are able to form a second bond 
with the metal cofactor through one of the sulfonamide oxygen (Supuran C.T. 2008).  
The difficulties and problems founded in designing new CAs inhibitors as 
therapeutical agents are mainly due to the large number of human isoforms (16 
human CAs, 13 of which have catalytic activity), the widespread location of the CA 
in many tissues/organs as well the lack of selectivity of the currently available 
inhibitors. 
For a long time, only primary sulfonamides and inorganic metal complexing 
anions were known to inhibit CAs, by coordinating to the metal ion from the enzyme 
active site.  These inhibitors are those described above. But, today are known 
inhibitor classes with a different mechanism of action such as a)	inhibitors anchoring 
to the nonprotein metal ion ligand, for example phenols, polyamines, hydrolyzed 
sulfocoumarins (i.e. sulfonic acids), some carboxylates, 2-thioxocoumarins; b) 
inhibitors occluding the active site entrance, an inhibition mechanism originally 
discovered for coumarins, which was then demonstrated to be similar to the CA 
activators (CAAs) binding mode; c) inhibitors which are out of the active site 
binding. This is the case of only one compound, an aromatic carboxylic acid 
derivative, found bound in an adjacent pocket to the active site entrance; d) inhibitors 
with an unknown binding mode, such as secondary/tertiary sulfonamide, protein 
tyrosine kinase inhibitors (e.g. imatinib/nilotinib). 
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1.7 Activators 
Activators of the CAs (CAAs) unlike CAIs, who have been extensively studied 
and are used in the clinic for prevention and treatment of various diseases, still 
represent an almost entirely unexplored field. There is a multitude of compounds 
such as biogenic amines (histamine, serotonin, catecholamines), amino acids, 
oligopeptides and small proteins, that are capable of effectively activate many CA 
isoenzymes. Several CAA design studies considered as lead molecules histamine or 
carnosine (Temperini C., et al. 2006; Nishimori I., et al. 2007). Through the use of 
techniques, such us electron spectroscopy, X-ray crystallography and kinetics 
measurements that activators bind at the cavity of the active site, while CA inhibitors 
bind to metal core. CAAs participate in the displacement of the protons between the 
metal ion, bound to a water molecule, and the environment. This determines an 
increase of the hydroxylated forms of the metal, which corresponds to the 
catalytically active form of the enzyme (Clare B.W. & Supuran C.T. 1994). In the 
last few years, have been reported the crystal structures of adducts formed by human 
isoforms hCA, hCAII and their activators (Temperini C., et al. 2007) in addition to 
those of histamine, dating to 1997 (Briganti F., et al. 1997). CAAs participate in a 
network of hydrogen bonds and hydrophobic interactions with specific amino acid 
residues or water molecules present in the active site. This explains their different 
power and ways of interaction with the various isoenzymes.  
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Chapter 2. Carbonic anhydrases from pathogens as 
druggable enzymes  
2.1 Pathogens 
The microorganisms that normally do not cause disease in humans are in a state 
of commensalism or mutualism with the host (Roux O., et al. 2011; Joyce S.A., 
Watson R.J., Clarke D.J. 2006; Soto W., Punke E.B., Nishiguchi M.K. 2012). This 
non-harmful condition occurs when the immune system works well, but the same 
organisms can cause infection when the latter fails. All microorganisms that cause 
diseases or illnesses to their host are defined as pathogens (Cardoso T., et al. 2012).  
Pathogens can be distinct into viruses, bacteria, fungi and protozoa. The 
pathogenicity of microorganisms is defined by the virulence, which is the ability of a 
pathogen to cause damage more or less severe in the host (Webb S.A. & Kahler C.M. 
2008; Grosso-Becera M.V., et al. 2015). Genetic characteristics, biochemical and 
structural properties of the pathogen influence the pathogen virulence, which allows 
the microorganism to cause disease through a set of actions on the host (Cardoso T., 
et al. 2012). These actions may be its ability to evade and/or fight the immune 
system, to assimilate nutrients from the host or to perceive environmental changes. 
All these abilities implicate the action of numerous enzymes. Enzymes considered as 
virulence factors are generally active against host components and contribute to 
virulence by damaging host tissues (Schaller M., et al. 2005; Alp S. 2006; Bostanci 
N. and Belibasakis G.N. 2012; Cox G.M., Mukherjee J., Cole G.T., et al. 2000; Cox 
G.M., McDade H.C., Chen S.C., et al. 2001). 
 
2.2 Bacterial CAs 
Prokaryotes include several kinds of microorganisms, such as Archaea, bacteria and 
cyanobacteria (Tibayrenc M. & Ayala F.J. 2012). It has been demonstrated that CAs 
are enzymes encoded by the genome of many pathogenic organisms. Recently, CAs 
started to be investigated in detail in several pathogenic bacteria, in the search for 
antibiotics with a novel mechanism of action, since it has been demonstrated that in 
many bacteria, CAs are essential for the life cycle of the organism. As reported in 
Table I, bacteria encode for enzymes belonging to the α-, β-, and γ-CA classes (Vullo 
D., et al. 2014; Nishimori I., et al. 2014; Alafeefy A.M., et al. 2014; Vullo D., et al. 
2013).  
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Table I. CAs from bacteria cloned and characterized so far, and their inhibition studies. 
 
 
 
Thus, the α-CAs from Neisseria spp, Helicobacter pylori and Vibrio cholerae as well 
as the β-class enzymes from Escherichia coli, Helicobacter pylori, Mycobacterium 
tuberculosis, Brucella spp., Streptococcus pneumoniae, Salmonella enterica and 
Haemophilus influenzae have been cloned and characterized in detail in the last few 
year. The N. gonorrhoeae α-CA has a molecular mass of 28 kDa, being rather 
homologous to mammalian CAs and showing high CO2 hydratase activity (similar to 
the human isoforms hCA II) as well as esterase activity for the hydrolysis of p-NpA. 
Instead, the H. pylori α-CA displayed an activity similar to that of the human isoform 
hCA I for the CO2 hydration reaction, being thus less efficient catalytically (see 
Table VI). (Cardoso T., et al. 2012; Cox G.M., et al. 2000; Cox G.M., et al. 2001; 
Bostanci N. & Belibasakis G.N. 2012; Alp S. 2006; Schaller M., et al. 
2005;Tibayrenc M., & Ayala F.J. 2012;Roux O., et al. 2011; Joyce S.A., et al. 2006; 
Nishiguchi MK. 2012; Krungkrai S.R., et al. 2001; Sein K.K. & Aikawa M. 1998; 
Joseph P., et al. 2011; Supuran C.T. 2008).  
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2.3 Protozoan CAs 
Malaria, a mosquito-borne disease of humans and other animal species, is caused by 
parasitic protozoa species belonging to the genus Plasmodium. Six different 
Plasmodium species infect humans: Plasmodium falciparum, Plasmodium vivax, 
Plasmodium ovale, Plasmodium malariae and the zoonotic Plasmodium knowlesi. 
Malaria parasites follow a complex lifecycle that involves an intermediate host such 
as humans and the definitive host, the mosquito vector. Following injection of 
sporozoite stage parasites from an infected female Anophelene mosquito into a 
human host, Plasmodium parasites move to the liver and invade hepatocytes where 
they replicate to form merozoites that are ultimately released into the blood 
circulation (Figure 12).  
  
 
 
 
 
 
 
 
 
Figure 12. Life cycle of the malaria parasite. 
 
Few protozoan parasites have been investigated for the presence and 
druggability of CAs. The malaria-provoking organism Plasmodium falciparum was 
undoubtedly the first one. Protozoa utilize purines and pyrimidines for DNA/RNA 
synthesis during its exponential growth and replication. Plasmodia synthesize 
pyrimidines de novo from HCO3-, adenosine-5’-triphosphate (ATP), glutamine (Gln), 
aspartate (Asp) and 5-phosphoribosyl-1-triphosphate (PRPP). HCO3- is the substrate 
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of the first enzyme involved in the Plasmodia pyrimidine pathway, which is 
generated from CO2 through the action of CA (Figure 13).  
 
 
 
 
 
 
Figure 13. Scheme of the pyrimidine metabolism in P. falciparum. Legend: PfCPSII, P. 
falciparum carbamoyl phosphate synthetase II; PfCTPs, P. falciparum cytidine 5′-
triphosphate synthase. HCO3− is generated from CO2 through the action of the η-CA. 
Studies from Krungkrai’s and our laboratories showed that Plasmodium spp. encode 
for several α-class CAs, and these enzymes have significant catalytic activity (as 
esterase with 4-nitrophenyl acetate as substrate) and are inhibited by primary 
sulfonamides, the main class of CAIs. The best investigated such enzyme has been 
denominated PfaCA1.  
 
2.4 Fungal CAs 
CAs are abundant in fungi and yeasts, but these enzymes have only recently started 
to be characterized and studied in detail. All known fungal CAs belong either to the 
α- or β-class (Elleuche & Pouggeler, 2009a). Fungal CA-encoding genes, like the CA 
multigene families in mammals, algae and plants, have diversified extensively during 
the evolution of fungi/yeast. The genomes of most filamentous ascomycetes contain 
three isoforms of β-class CAs and at least one α-class CA, whereas only β-class CAs 
have been identified in hemiascomycetous yeasts (Elleuche & Po¨ggeler, 2009a). 
Within the basidiomycetes, only Cryptococcus neoformans encodes two β-CAs, 
while the genome of Coprinopsis cinerea, Laccaria bicolor, Malassezia globosa and 
Ustilago maydis contains single β-CA genes (Elleuche & Po¨ggeler, 2009a). 
Interestingly, eight genes encoding putative α-CAs can be identified in the genome 
of L. bicolor (S. Po¨ggeler, unpublished). β-CAs have been functionally 
characterized in only a few fungal species. Saccharomyces cerevisiae, Candida 
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albicans and Candida glabrata each have only one β-CA, whereas multiple copies of 
β-CA- and α-CA-encoding genes were reported in other fungi. Recent work 
demonstrated that these CAs play an important role in the CO2-sensing of the fungal 
pathogens and in the regulation of sexual development. In fact physiological 
concentrations of CO2/HCO3- induce prominent virulence attributes in C. albicans 
(filamentation) and C. glabrata or Cryptococcus neoformans (capsule biosynthesis) 
through direct activation of the fungal adenylyl cyclase (Bahn et al., 2007; (Klengel 
et al., 2005). CO2/HCO3- equilibration by fungal β-CAs equally plays thus a critical 
part in fungal CO2 sensing and pathogenesis. For example, the C. albicans enzyme 
CaNce103 or the analogous C. glabrata one (CgNce103) are essential for 
pathogenesis of these fungi in niches where the available CO2 is limited (e.g., the 
skin), or essential for the growth of C. neoformans in its natural environment (the 
enzyme from this last pathogen is denominated Can2) (Bahn et al., 2005; Go¨tz et 
al., 1999; Innocenti et al., 2009; Klengel et al., 2005). Thus, the link between cAMP 
signaling and CO2/HCO3- sensing is conserved in fungi and revealed CO2 sensing to 
be an important mediator of fungal metabolism and pathogenesis. The gene Nce103 
is also present in the model organism S. cerevisiae (Cleves., et al., 1996). This 
protein is required to provide sufficient HCO3- for essential metabolic carboxylation 
reactions of the yeast metabolism, such as those catalyzed by pyruvate carboxylase, 
acetyl-CoA carboxylase, carbamoyl phosphate synthase and 
phosphoribosylaminoimidazole (AIR) carboxylase (Aguilera et al., 2005b). Thus, 
this enzyme (called ScCA) has also been cloned and investigated in detail for its 
inhibition and activation with a range of modulators of activity. Interestingly, an 
additional putative cab-like β-CA has been identified in the pathogenic yeast C. 
albicans (XP_715817) and in Pichia stipitis (XP_001383682.1) (Elleuche & 
Po¨ggeler, 2009a). Recently, a multigene family of β-CAs was shown to influence 
the sexual development of the filamentous ascomycete Sordaria macrospora 
(Elleuche & Po¨ggeler, 2009b). CA activity from secreted CA isoforms has also been 
detected in various Penicillium isolates, and this activity is believed to be involved in 
limestone dissolution (Li et al., 2009). Finally, another yeast, which has been 
investigated in detail for the presence of CAs is Malassezia globosa, which produces 
dandruff. As the above-mentioned fungi/yeasts, it contains only one β-CA, 
denominated MgCA. Only for the Malassezia enzyme (MgCA) some in vivo studies 
have been performed, but not for the other fungal CAs. 
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Chapter 3. Scope of the thesis 
Cloning the genomes of many pathogenic microorganisms offered the possibility of 
exploring alternative pathways for inhibiting virulence factors or proteins essential 
for their life cycle (Sainsbury P.D., et al. 2015). Using this approach, carbonic 
anhydrase has been identified in the genome of bacteria, fungi and protozoa, as a 
new class of enzymes related to microbial virulence (Capasso C. & Supuran C.T. 
2013). 
The aims of the present thesis are: 
1. Biochemical studies and inhibition profile of CAs encoded by the genome of 
two pathogenic bacteria, Vibrio cholera and Porphyromonas gingivalis.  
Vibrio cholerae is the causative agent of cholera. The microorganism colonizes the 
upper small intestine where sodium bicarbonate is present at a high concentration. 
Vibrio cholerae genome encodes for three distinct classes: α-CA originated from the 
cah gene VC0395_0957, a β-CA derived from the gene VC0395_A 0118 and a γ-CA 
encoded by the gene VC0395_A2463. These CAs were designated as VchCA (α-
CA), VchCAβ (β-CA) and VchCAγ (γ-CA). It has been demonstrated that sodium 
bicarbonate is an inducer of virulence gene expression in Vibrio (Cash R.A., et al. 
1974). Since V. cholerae lacks of bicarbonate transporter proteins in its genome, it 
has been hypothesized that the pathogen utilizes the CAs system to accumulate 
bicarbonate into the cell to activate its virulence.  It was investigated the inhibition 
profiles of VchCA, VchCAβ and VchCAγ in the presence of inorganic anions 
complexing metals and organic ligands represented by the sulfonamides and related 
bioisosteres (sulfamates, sulfamides, hydroxamate and xanthates). 
Porphyromonas gingivalis is a pathogen, which colonizes the oral cavity and is 
involved in the pathogenesis of periodontitis, an inflammatory disease leading to 
tooth loss. The genome of P. gingivalis encodes for β- and a γ-CAs. It has been 
investigated their inhibition profile with a range of inorganic anions and organic 
ligands. The role of CAs as possible virulence factors of P. gingivalis is poorly 
understood at the moment but their good catalytic activity and the fact that they 
might be inhibited by a large number of compounds might pave the way for finding 
inhibitors with antibacterial activity that may elucidate these phenomena and lead to 
novel antibiotics 
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2. Biochemical characterization and inhibition studies of the carbonic 
anhydrase from Plasmodium falciparum. 
Plasmodium falciparum is responsible for the most severe and life-threatening form 
of malaria. The antimalarial drugs represent a keystone of malaria control. Few 
protozoan parasites have been investigated for the presence and druggability of CAs 
and P. falciparum was one of the first protozoa to be investigated for the presence of 
CAs. The P. falciparum CA gene (accession number AAN35994.2) encodes a 600 
amino acid polypeptide chain. In 2004, it was cloned a truncated form of this gene 
encoding for a polypeptide chain formed by the amino acid residues from position 
211–445, named PfaCA1 and designed as a α-CA. Here, it has demonstrated that 
PfCA1 is not a α-CA but it belongs to the η-class, being however sensitive to 
sulfonamide inhibitors. 
 
3. Cloning, expression and purification of the β-carbonic anhydrase from the 
pathogenic yeast Malassezia globosa. 
The genome of the fungal parasite Malassezia globosa, the causative agent of 
dandruff, contains a single gene encoding a CA belonging to the β-class (MgCA). 
Inhibition studies of these enzymes with anions and sulfonamides have been 
performed, which led to the detection of several inhibitors with high affinity. This 
study may help a better understanding of the inhibition profile of this enzyme and 
may offer the possibility to design new such modulators of activity belonging to 
different chemical classes 
 
4. Protonography 
It was set up a simple and inexpensive technique to assay CA activity on SDS-PAGE 
gels, named “protonography”. By using protonography, the conversion of CO2 into 
protons can be visualized as a yellow band on a polyacrylamide gel. 
 
5. Phylogenetic analysis of the bacterial CAs 
The complex distribution of the various CA classes in Gram-positive and negative 
bacteria allowed me to find a correlation between the evolutionary history of the 
bacteria and the three CA classes (α, β and γ) identified in their genome. In the 
present thesis was demonstrated that the ancestral CA is represented by the γ-CA, 
while the most evolute form of CA, among all the CA-classes, is the α-CA 
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Chapter 4. Materials and Methods 
4.1 Identification and synthesis of the CA genes.  
To determine the presence of carbonic anhydrases have been used similarity 
searching programs, such as BLAST and FASTA. As query sequences were used the 
amino acid sequences of CAs belonging to α-, β- or γ-class. The analysis performed 
on Vibrio cholerae genome identified three classes of carbonic anhydrase: the α-CA, 
indicated with the acronym VchCA; the β-CA, named VchCAβ; and the γ-CA, called 
VchCAγ. The computational search showed that the genome of Porphyromonas 
gingivalis encoded for β- and γ –CAs, named PgiCAb and PgiCA, respectively. The 
investigation of the Malassezia globosa genome produced as result the identification 
of a β-CA, named MgCA. In the case of the protozoan Plasmodium falciparum, the 
gene encoding for the ƞ-CA (PfCA1) was kindly provided by Prof. Sally-Ann 
Poulsen Griffith University, Brisbane, Australia. The GeneArt Company 
(Invitrogen), specialized in gene synthesis, designed the synthetic genes encoding for 
VchCA, VchCAβ, VchCAγ, PgiCAb, PgiCA and MgCA. The single genes were 
inserted in a propagation vector (pMK-T). Escherichia coli competent cells (DH5α) 
were transformed with the aforementioned vector for the gene amplification and 
storage.  
 
4.2 Bacterial strains used for plasmid propagation and 
heterologous protein expression. 
4.2.1 E. coli DH5α 
Competent Cells Subcloning Efficiency ™ DH5α ™ (Life Technologies) are 
generally used to propagate plasmids and have good processing efficiency. This 
strain carries a mutation that inactivates the endonuclease I (endA1) that could 
degrade the plasmid DNA during the extraction, and a mutation which inactivates the 
endonuclease EcoK I, but not the methylase activity (hsdR17 (RK, mk +). These 
cells lack the recombinase recA1 that is responsible for the recombination between 
the plasmid and the E. coli genome, making the plasmid more stable. They can also 
be used to blue/white screen for bacterial plates containing Blu-gal or X-Gal. More 
details on the genotype are shown in table II. 
	 26	
4.2.2 E. coli BL21(DE3) 
E. coli BL21 host strain is the most used in standard applications of recombinant 
expression. BL21-Gold (DE3) (Agilent) is a robust strain of E. coli, able to grow 
vigorously in minimal media (Chart et al., 2000). This strain presents the Hte 
phenotype, which increases the efficiency of transformation of the cells. In addition, 
the strain lacks of proteases OmpT and Leon, which can degrade the recombinant 
protein intact; and of endonuclease (endA), which can degrade the plasmid DNA 
isolated from mini preparations. The table II shows other details of the cell genotype. 
The host strain lysogenized from the phage DE3 fragment, presents a copy of the 
bacteriophage T7 gene 1 integrated in the genome, which encodes the T7 RNA 
polymerase. Such gene is under the control of the promoter lacUV5 (derivative of the 
lac promoter) sensitive to the adjustment by the cAMP-CRP complex and inducible 
by isopropyl-β-D-1-tiogalattopiranoside (IPTG) (Studier & Moffat 1986). The T7 
RNA polymerase drives the expression of the gene encoding for the recombinant 
protein. 
4.2.3 E. coli ArcticExpress (DE3) 
The strain of competent cells ArcticExpress (DE3) (Agilent) has the 
characteristics described above for the strain BL21-Gold (DE3) (Agilent). In 
addition, these cells are designed to deal with the problem of the insolubility of 
proteins, which may occur during the expression of the recombinant proteins. Arctic 
Express (DE3) cells, in fact, express proteins chaperone Cpn10 and Cpn60 of the 
psychrophilic bacterium Oleispira antarctica. These chaperonins have an amino acid 
identity with the chaperonins GroEL and GroES of E. coli by 74% and 54%, 
respectively, and show a good activity of protein folding at temperatures between 4 ° 
C and 20 ° C. These chaperonins, once expressed in cells ArcticExpress, optimize 
production of the heterologous protein at low temperatures and, presumably increase 
the amount of soluble and active recombinant protein produced. See table II for more 
details on the genotype. 
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Table II. Host strain genotype 
Host strain Genotype 
BL21-(DE3) 
E. coli B F- ompT hsdS(rB- mB- ) dcm+ Tetr gal λ(DE3) 
endA The 
ArcticExpress (DE3) 
E. coli B F- ompT hsdS(rB- mB-) dcm+ Tetr gal λ(DE3) 
endA Hte [cpn10 cpn60 Gentr] 
Subcloning Efficiency™ DH5α™ 
F- Φ80lacZΔM15Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17 (rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ- 
 
4.3 Culture medium: LB (Luria-Bertani) 
The culture medium LB (Luria-Bertani), nutritionally rich and designed for the 
growth of pure cultures of recombinant strains, is prepared by dissolving 20g of the 
prepared powder (LB BROTH, LENNOX-Laboratories Conda) per liter of distilled 
water and sterilized by autoclaving at 121°C for 20 minutes. Heat-labile substances, 
such as antibiotics and IPTG, are added after sterilization and filtered with Millipore 
Millex-GP filter (0,22µm) during the preparation.  
4.4 Expression vector: pET15b (Novagen) 
The expression vector pET-15b (5708 bp) is constituted by an origin of 
replication and the gene for β-lactamase, which confers resistance to the antibiotic 
ampicillin, in addition to the viral T7 promoter, a multiple cloning site (MCS) for the 
enzymes restriction most common and a sequence that encodes a tag of histidines. 
The recombinant protein is expressed with the tag of histidines at the N-terminal 
(Figure 14), which allows the rapid purification of the recombinant protein by 
affinity chromatography using a specific resin loaded with metal ions. Furthermore, 
in the vector a cutting sequence recognized by the enzyme thrombin allows removal 
of the fusion tag. The expression of the gene cloned into the vector is controlled by 
the T7 promote and recognized specifically by the T7 RNA polymerase of E. coli. Its 
expression is induced by 'isopropyl-β-D-1-tiogalattopiranoside (IPTG). Once the 
polymerase has reached a sufficient expression level, it binds to the promoter and 
initiates transcription. 
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Figure 14. pET-15b Novagen cloning/expression region 
 
4.5 Cloning procedure 
4.5.1 Construct preparation 
The CA gene encoding for the recombinant protein have been designed using the 
Life Technologies software. All the genes encoding for a α-CAs were devoid of the 
signal peptide (first twenty amino acid residues of the peptide sequence) and fused at 
the N-terminal with a tag of histidines essential for the subsequent purification of the 
protein. These genes were synthetized and inserted by Life Technologies in the 
plasmid pMK-T, containing cleavage sites for the restriction enzymes NdeI and XhoI 
at the 5 'end and 3' of the genes, respectively. Subsequently, it was shipped to the 
laboratory. The 5 µg of plasmid aforementioned in lyophilized form were 
resuspended in 15µl RNase free water. The concentration was determined using the 
NanoDrop ™ 1000 Spectrophotometer (Thermo Scientific). The DNA was stored at -
20°C. 
4.5.2 Plasmid DNA amplification into E. coli DH5α cells 
The pMK-T cloning vector prepared as above was amplified using competent 
cells of E. coli DH5α. An aliquot of 50 µl of cells, stored at -80°C, was thawed on 
ice for 2-5 minutes and transformed with 100 ng of plasmid DNA. The cell 
suspension was mixed gently and placed on ice for 30 min. and then subjected to 
heat shock (42° C for 20 sec). After the addition of 950 µL of LB medium preheated, 
the mixture of transformation was incubated for 1 h at 37 ° C on a horizontal shaker 
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(CERTOMAT® BS-1), at a speed of 200 rpm. Then, a quantity ≥ 200 L of the 
mixture of transformation, were plated on solid medium (LB-Agar + kanamycin 
50µg / ml) and the plates were incubated over-night at 37 ° C. To obtain higher 
quantities and a better purity of the plasmid DNA, it was set up a maxi preparation, 
for which a single bacterial colony was inoculated into 200 ml of LB containing 
ampicillin 100 mg/ml and made to grow at 37 ° C for 16 hours. The culture was then 
centrifuged at 5000xg for 5 minutes and the pellet treated using The PerfectPrep 
EndoFree ™ Plasmid Maxi Kit (5 PRIME), following the procedures described in 
the manual. Briefly, the plasmid DNA was then adsorbed on a column of silica gel 
and separated from RNA, proteins and other cellular components. The final elution 
was achieved with ribonuclease free water. The DNA was stored at -20°C. 
4.5.3 Vector digestion 
The expression vector pET-15b was digested with the restriction enzymes NdeI 
and XhoI (Biolabs, New England). The digestion of the plasmid DNA was carried 
out for 60 minutes at 37°C using 50 U of enzyme NdeI, and 50 U of XhoI enzyme in 
a reaction mixture containing 3 micrograms of BSA in Tris-HCl 6mM pH 7.5 
containing 6 mM MgCl2, 50 mM NaCl and 1 mM DTT. The reaction was conducted 
in a final volume of 30 µl. After digestion, the linearized plasmid was treated with 
0.1 U of bovine alkaline phosphatase and incubated at 37°C for 30 minutes. The 
alkaline phosphatase determines the dephosphorylation of the linearized plasmid to 
prevent it can reclose on itself. The sample was then loaded on 1% agarose gels in 
TAE buffer (Tris-acetate-EDTA). The run was conducted using a horizontal 
electrophoresis apparatus for 40 minutes at 90V. As molecular weight marker was 
used a mixture of DNA fragments of known size (1 Kb Plus DNA Ladder ™ Thermo 
Fisher Scientific). Agarose gel was prepared adding ethidium bromide to a final 
concentration of 1µg/ml, to visualize the fragments of DNA by irradiation of the gel 
with ultraviolet light. The band corresponding to the linearized plasmid with NdeI 
and XhoI was excised from the gel and purified using Agarose GelExtract Mini Kit 
(5 Prime). The concentration of the purified plasmid was determined using the 
NanoDrop ™ 1000 Spectrophotometer (Thermo Scientific). Similarly, the pMK-T 
cloning vector, containing the genes coding for the CAs, was digested with the 
restriction enzymes NdeI and XhoI (Biolabs, New England). The band corresponding 
to the DNA encoding for CAs ( VchCA or VchCAβ or VchCAγ, PgiCAb or PgiCA) 
was excised from the gel and purified using Agarose GelExtract Mini Kit (5 
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PRIME). The concentration of the purified fragment was determined by NanoDrop 
™ 1000 Spectrophotometer (Thermo Scientific).  
4.5.4 Ligation Reaction 
50 ng of the fragment corresponding to the DNA encoding for CAs (VchCA or 
VchCAβ or VchCAγ, PgiCA, PgiCAb) was ligated into the expression vector pET-
15b (100 ng).  Constructs pET-15b/VchCA, pET-15b/VchCAβ and pET-
15b/VchCAγ, pET-15b/PgiCA, pET-15b/PgiCAb were generated. The ligation 
reaction was carried out at 16 °C for 16 hours in the presence of 400 U of T4 DNA 
ligase supplied in 10 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 1 mM DTT, 200 mg / 
ml BSA and 50% glycerol, and 1X T4 DNA ligase buffer (50 mM Tris-HCl pH 7.5, 
10 mM MgCl2, 10 mM DTT, 1 mM ATP, 25 mg / ml BSA) (New England 
BioLabs).  
Three µL of the ligation reaction were used to transform XL10-Gold 
Ultracompetent cells (Stratagene) with high efficiency of transformation. The 
transformation was performed by thermal shock, and the cells plated on medium 
containing as ampicillin 100 µg/ml (pET-15b contain the gene for ampicillin 
resistance) 
 
4.5.5 Clone identification 
Ten colonies grown on LB-agar plate with ampicillin 100 µg/ml were analyzed 
to verify the presence of the gene encoding the CA of interest in the construct 
prepared as described above. For this purpose, the plasmid DNA was extracted from 
the colonies selected using the “The PerfectPrep EndoFree Plasmid Maxi” kit (5 
PRIME) based on the method of lysis with alkali as described by Sambrook et al. 
1992. Each bacterial colony was inoculated in 200 ml of LB containing ampicillin 
100 µg/ml and grown at 37°C overnight. The cultures were then centrifuged at 
6000xg for 5 min at 4°C and the resulting pellet suspended in Tris-HCl 10 mM pH 
8.3. The bacterial suspension was lysed under alkaline conditions and the lysate 
neutralized in a buffer with a high salt concentration. The plasmid DNA was then 
adsorbed on a column of silica gel and separated from RNA, proteins and other 
cellular components. The final elution was achieved by water ribonuclease free. To 
verify that the gene encoding for VchCA or VchCAβ or VchCAγ or PgiCA or 
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PgiCAb was correctly inserted, the purified plasmid DNA (100 ng/µL) was 
sequenced using the PRIMM service. 
 
4.5.6 Construct amplification 
The amplification of the expression plasmid pET-15b containing the gene 
encoding for the CA of interest (VchCA or VchCAβ or VchCAγ or PgiCA or 
PgiCAb) was performed as described previously. 
 
4.6 Expression of heterologous proteins in E. coli cells 
4.6.1 Small-scale optimization 
To optimize the conditions for the expression of recombinant proteins, growth 
was performed in a small scale. After the addition of IPTG, the production of 
proteins of interest was monitored at different times of incubation (2h, 4h, 6h, and 
overnight). Moreover, it has also been used different concentrations of IPTG (0.1 
mm, 0.5 mm, 1 mM). Aliquots of samples were analyzed by SDS-PAGE. 
 
4.6.2 Large-scale expression  
For the heterologous expression of VchCA, VchCAβ, PgiCAb and PgiCA it has 
been used E. coli BL21 (DE3) cells; for the expression of VchCAγ and PfCA1 it has 
used ArcticExpress (DE3) cells and while for the expression of MgCA it has used E. 
Coli BL21 (DE3) Codon Plus. Competent expression cells were transformed using 
the thermal shock technique, which facilitates the passage of DNA through bacterial 
wall. Briefly, 50 µl of competent cells stored at -80°C, was thawed on ice for 
approximately 5 minutes. Then, the cells were incubated with for 10 minutes on ice 
in presence 1 µl of β-mercaptoethanol (1.42 M) and subsequently transformed with 
100 ng of plasmid DNA. The cell suspension was mixed gently and placed on ice for 
30 min. After the addition of 950 µL of LB medium preheated, the mixture of 
transformation was incubated (1 h at 37°C on a horizontal shaker at a speed of 200 
rpm). Then, a quantity ≥ 200 L of the mixture of transformation, were plated on solid 
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medium (LB-Agar + Ampicillin, 100µg/ml) and the plates were incubated overnight 
at 37°C. Two-three bacterial colonies were inoculated into 100 ml of LB containing 
ampicillin and grow at 37°C for 16 hours. The culture was diluted 10 times with 
fresh LB medium containing ampicillin and incubated at 37°C and grown to the 
value of optical density at 600 nm of 0.6. Differently, ArcticExpress (DE3) and 
BL21 (DE3) Codon Plus cells were pre-incubated at 30 °C and once reached the 0.6 
optical densities at 600 nm shifted to 20 °C. Then the cells transformed with the 
construct pET-15b/VchCA, pET-15b/VchCAβ, pET-15b/PgiCAb, pET-15b/PgiCA 
and pET-15b/MgCA were induced with 1 mM IPTG, while those transformed with 
the construct pET-15b/VchCAγ and pET-43.1a/PfCA1 were induced with IPTG 0.5 
mM. After half an hour from the induction with IPTG, ZnSO4 was added to the 
culture at a concentration of 0.5 mM. The metal ion was added because the zinc ion 
is essential for the catalytic activity and for the folding of the CA. Depending on the 
type of construct containing the CA of interest, after 4, 5, 6 or 20 hours cells were 
harvested by centrifugation at 6000xg for 30 minutes in Sorvall RC 6 Plus ™ 
(Thermo Scientific). 
 
4.7 Purification and characterization of the recombinant CA  
4.7.1 Affinity chromatography 
Bacterial cells previously collected were suspended in 10 mM Tris-HCl pH 8.3 
(Vf = 50 ml), lysed by sonication using a Branson Digital Sonifier using 15 cycles of 
10sec with a 50 % of power. The sonicate was centrifuged at 10000xg for 45 minutes 
in Sorvall RC 6 Plus ™ (Thermo Scientific). All operations were performed at 4 °C. 
The supernatant was collected and purified by affinity chromatography on column 
HisTrapTM FF crude 1 ml (GE Healthcare Bio-sciences) connected to an AKTA 
FPLC system. The column resin (Chelatin SepharoseTM High Performance) is 
agarose linked to iminodiacetic acid, able to chelate metal ions such as Ni2+ ions 
capable of coordinating the imidazole groups of the His-tag of our proteins (Figure 
15). 
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Figure 15. Schematic representation of His-Tag bounded to the beads of HisTrapTM FF 
column 
 
The column was prepared by passing approximately 20 ml of Milli-Q H2O (0.5 ml / 
min) and equilibrated with 10 column volumes of buffer A (20 mM imidazole, 20 
mM phosphate buffer, 0.5 M NaCl pH 8 to a flow of 1 ml/min). Sample was loaded 
on the column at a constant flow of 1ml/min. Subsequently, washing was performed 
with 40 ml of buffer A. The protein, bound to the resin, was specifically eluted using 
an elution buffer (250 mM imidazole, 20 mM phosphate buffer, 0.5 M NaCl, pH 8) 
at a flow rate of 1 ml/min. Fraction were collected by recording the absorbance at 
280 nm and dialyzed against 10 mM Tris-HCl, pH 8.3. Dialysis was performed at 
4°C and using tubes with a cut-off of 12000 Daltons, in order to remove the high 
concentration of imidazole used for the elution. The dialyzed protein was collected 
and analyzed by SDS-PAGE. 
 
4.7.2 SDS-PAGE analysis of protein fractions 
The SDS-PAGE analysis of protein fractions obtained as described in the previous 
section was conducted according to the method described by Laemmli (1970). Each 
sample was dissolved in SDS Sample Buffer (62.5 mM Tris-HCl pH 6.8; 10% 
glycerol; 2% SDS; 10% β-mercaptoethanol; Bromophenol Blue 0.05%) and heated 
for 7 minutes at 100 °C to denature proteins. After this treatment, samples were 
subjected to vertical electrophoresis by loading 20 µl of each sample on a 
polyacrylamide gel at 12.5%. The electrophoretic run was performed on Mini-
PROTEAN® Tetra Vertical Electrophoresis Cell (BioRad) at a constant voltage of 
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150 V for about an hour, using the running buffer 1X Tris-Glycine SDS buffer, pH 
8.3 (250 mM Tris base, 192 mM glycine and 1% SDS). A molecular weight marker 
ranging from 10-250 kDa (Precision Plus Protein ™ Dual Color Standards, BioRad) 
was used as standard. The protein bands were visualized by soaking the gel in the 
Staining Solution (0.025% Coomassie R-250; 50% methanol; 10% acetic acid; Milli-
Q H2O to a volume of 1 L) and subsequently in destaining Solution (10% methanol; 
acid 10% acetic; Milli-Q H2O to a volume of 1 L). To calculate the molecular mass 
of the protein in question has been used the program Compute pI/Mw (Gasteiger et 
al., 2005), accessible from the server of Molecular Biology ExPASy. 
 
4.7.3 Determination of protein concentration 
The protein concentration was determined by the Bradford assay (Bio-Rad 
Laboratories, Hercules, USA) that is based on the color variation of an acidic 
solution of Coomassie Brilliant Blue G-250 (Bio-Rad mix, max of absorption at 465 
nm) in presence of protein. The color change results in an increase in absorbance 
from 465 nm to 595 nm, which is proportional to protein concentration. The 
calibration curve was constructed using known amounts of bovine serum albumin 
(BSA). For each sample (20 µL) were added 200 µL of the coloring solution Quick 
Start Bradford Dye Reagent 1x (BioRad) and water to reach the final volume of 1 ml. 
The blank was prepared with 20 µl of the buffer used for harvesting the cells. The 
samples thus prepared were incubated 5 minutes at room temperature and read in a 
spectrophotometer at a wavelength of 595 nm. A three points calibration curve was 
prepared using known amounts of BSA. The sample unknown concentration was 
calculated using the first-degree equation determined from the BSA calibration 
curve. 
4.7.4 Determination of the CA hydratase activity in solution 
The CAs activity assay is a modification of the procedure described by Chirica 
(Chirica L.C., et al. 1997) and is based on monitoring the change in pH due to the 
catalytic conversion of CO2 into bicarbonate. The indicator of the variation of pH is 
bromothymol blue (BTB) (Sigma-Aldrich). The assay was performed at 0°C in a 
final volume of 1 ml. The CO2 saturated water was prepared by bubbling CO2 into 
100 mL of distilled water for about 3 h. To test the activity of the enzyme, 100 µL of 
250 mM Tris-HCl pH 8.3 containing BTB (to give a distinct and visible blue color), 
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were placed in two tubes cooled in ice. Ten to 50 µl of enzyme solution (purified 
enzyme in 10 mM Tris-HCl pH 8.3) were added to a test tube and, an equivalent 
amount of buffer was added to the second tube as a control. Immediately have been 
added 500 µl of water saturated with CO2 and 400 µl of Milli-Q water and 
simultaneously a stopwatch was started. The time taken for the color change of the 
solution from blue (alkaline pH) to yellow (acidic pH) was recorded (the range of 
color change is between pH 6.0 and pH 7.6). The production of H+ during the 
reaction of hydration of CO2 lowers the pH of the solution up to the transition point 
of the dye. The time required for the color change is inversely proportional to the 
quantity of CA present in the sample. Next, we have calculated the Wilbur-Anderson 
units (WAU). One WAU of activity is defined as: (T0 - T) / T, where T0 (reaction not 
catalyzed) and T (reaction catalyzed) represent the time (in seconds) necessary so 
that the pH falls from 8, 3 up to the transition point of the dye, in the control buffer, 
and in the sample in which is present enzyme respectively. 
4.7.5 α-CA esterase activity assay  
Differently from the other CA classes, the α-CAs are able to hydrolyze the ester p-
nitrophenyl acetate (p-NpA) in p-nitrophenolate and acetate. The activity of 
hydrolysis of p-NpA was determined using a modification of the method proposed 
by Armstrong (Armstrong J.M., et al. 1966). The reaction mixture was composed as 
follows: 300 µl of p-NpA 3mM, 700 µl 15mm Tris Sulfate buffer at pH 7.6 and 10µl 
of enzyme. The hydrolysis of p-NpA was monitored by the increase of p-
nitrophenolate, which was measured at 348nm for 5 minutes using a 
spectrophotometer Varian's Cary 50 (Agilent Technologies). The catalyzed reactions 
were corrected for the non-enzymatic reaction. One unit of enzyme was defined as 
the amount of enzyme capable of producing an OD348nm = 0.03 in 5 minutes. 
4.7.6 Protonography 
It was set up a simple and inexpensive method, similar to zymography, which 
allowed the detection of CA activity on the polyacrylamide gel following the 
formation of H+ ions produced by hydratase of CAs. The technique was called 
"protonography” (De Luca V., et al. 2015). Briefly, samples were run on SDS-PAGE 
at a concentration of about 4 µg per well. The commercial bovine CA (bCA) was 
used as a control. SDS-Page was carried out as described in the section “SDS-PAGE 
analysis of protein fractions”, with the exception that the SDS sample buffer didn’t 
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contain the β-mercaptoethanol and samples were not heated. Two SDS-PAGE gels 
were prepared: one was stained with Coomassie blue; the other was used to develop 
the protonogram. The last one was, in fact, treated with Triton X-100 at 2.5% and 
kept under stirring for one hour to remove the SDS. The gel was subjected to a 
washing step of 20 min with 100 mM Tris-HCl, pH 8.3, containing 10% isopropanol. 
It was washed two times for 10 minutes. Finally, the gel was incubated for 30 
minutes at 4 °C under stirring with 0.1% bromothymol blue (BTB) in 100 mM Tris-
HCl pH 8.3. BTB is a pH indicator. To detect the hydratase activity, the gel was 
immersed in distilled water saturated with CO2 prepared by bubbling CO2 into 200 
mL of distilled water for about 3 h. The localized decrease of the pH value, due to 
the presence of the enzymatic activity of CAs, was detected through the formation of 
yellow band due to the change of color of the BTB from blue (alkaline pH) to yellow 
(acidic pH). 
 
4.7.7 Thermoactivity  
The temperature dependence activity of VchCA was determined using the p-
NpA as substrate. The results were compared with that obtained for the bovine CA 
(bCA). In the assay were used 300 ng of protein. The reaction mixture was set up as 
described in the previous paragraph and the activity was measured at the 
temperatures ranging from 25 to 100°C. 
4.7.8 Thermostability 
The CA thermal stability was evaluated through experiments of thermal 
inactivation. The recombinant CAs were incubated at 25, 40, 50, 60, 70, 80, 90 and 
100°C and aliquots were withdrawn at different times (30, 120 and 180min). Enzyme 
concentration was 3µg/mL in a buffer composed of Tris-HCl 10 mM, pH 8.3. The 
enzyme residual activity, expressed in percent of WAU, was measured at 0°C using 
CO2 as a substrate. The results were compared with those obtained for a mesophilic 
enzyme (bCA) 
4.7.9 Determination of the kinetic and inhibition constants  
The kinetic and inhibition constants were obtained using the “stopped flow” 
apparatus. The apparatus (Applied Photophysics) is positioned in the laboratory 
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direct by Prof. Claudiu Supuran, where have been collected all the kinetic results. 
The apparatus is made up of two main components: the mixing chamber and the 
observation chamber. As pH indicator it has been used phenol red (0.2mM), which 
operates at a maximum absorbance of 557 nm with HEPES buffer (acid 4-2-
hydroxyethyl-1-piperazinyl-ethanesulfonic acid, an organic substance used to 
maintain the stable pH) 10 mM at pH 7.5 (for the α-CAs) or 20 mM Tris (pH 8.3 for 
β- and γ- CA) and 0.1 M NaClO4 (to maintain ionic strength constant) at 20°C. The 
reaction was followed for a period of 10-100 sec (the reaction is not catalyzed needs 
about 60-100 sec under the test conditions, while the reactions catalyzed need about 
6-10 sec). For the determination of kinetic parameters and inhibition constants, the 
concentrations of CO2 are comprised between 1.7 and 17 mM. Stock solutions of 
inhibitor (10-50 mM) were prepared in deionized-distilled water and then, with the 
Assay Buffer were made dilutions to 0.01 µM. The inhibitor and the enzyme 
solutions were pre-incubated for 15 minutes at room temperature before assay, in 
order to allow the formation of the E-I complex (enzyme-inhibitor) or to the possible 
hydrolysis of the inhibitor, mediated by the active site. The kinetic parameters were 
determined using the diagram Lineweaver-Burk plot (or diagram of the double 
reciprocal), while the inhibition constants were obtained by the method of nonlinear 
least squares using PRISM 3 and represent the average of at least three different 
determinations. 
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Chapter 5. Vibrio cholerae CAs  
Bacteria can increase cytosolic levels of bicarbonate through the transporters of 
the bicarbonate or through the action of enzymes, the carbonic anhydrase (CA), 
which convert the CO2 to bicarbonate or metabolic than atmospheric entry into the 
cells by simple diffusion (Smith K.S. & Ferry J.G. 2000). The analysis of the genome 
of Vibrio cholerae through the use of the program FASTA (Pearson W.R., 1994) has 
evidenced the absence of nucleotide sequences of the bicarbonate transport system 
similar to those identified in S. elongates. It was hypothesized that V. cholerae uses 
the enzymatic system of the carbonic anhydrase to accumulate bicarbonate inside the 
cell. (Del Prete S., et al. 2014). From the inspection of the V. cholerae genome, 
carried out using the BLAST program, it was found that the pathogen encoded for 
three classes of carbonic anhydrase: the α-class CA, encoded by the gene cah 
(VC0395_0957), indicated by the acronym VchCA; the β-CA derived from the gene 
VC0395_A 0118, indicated by the acronym VchCAβ and a γ-CA encoded by the 
gene VC0395_A2463, indicated with the acronym VchCAγ. In prokaryotes, the 
existence of genes encoding CAs from at least three classes (α-, β- and γ-class) 
suggests that these enzymes play an important role in the prokaryotic physiology. 
 
5.1 VchCA 
VchCA is a carbonic anhydrase belonging to α class and consists of 239 amino 
acid residues. The figure 16 shows the alignment of VchCA with human (isoform 
hCAI and II) and bacterial α-CAs (hpyCA identified in the bacterium Helicobacter 
pylori; NgonCA identified in Neisseria gonorrhoeae).  
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Figure 16. Multialignment of amino acid sequences of the α-CAs encoded by the 
genome of Vibrio cholerae and other sources (see text for details) performed with the 
ClustalW program, version 2.1. Numbering system of hCAI was used. It has been reported 
the proton shuttle residue (dark green) and the gate-keeping residues (Asp, light green; Thr, 
blue).Legend: hCAI, Homo sapiens, isoform I; hCA II, Homo sapiens, isoform II; hpyCA, 
Helicobacter pylori; NgonCA, Neisseria gonorrhoeae; VchCA, Vibrio cholerae.  
 
VchCA shows an identity of about 30% with the two human isoforms and 40% 
with bacterial CAs. Moreover, VchCA conserved all the characteristics common to 
other α-CAs, for example the amino acid residues of the catalytic triad, the proton 
shuttle and the gate-keeping residues. (Figure 16). 
 
5.2 VchCAβ 
VchCAβ is a β-CA formed by a polypeptide chain of 222 amino acid residues 
showing an identity of 40%, when compared with the β-CAs from Flaveria bidentis 
(FbiCA) and Pisum sativum (PsaCA) and, 30% when compared with the bacterial β-
CAs from Porphyromonas gingivalis (PgiCA) and Brucella suis (BsuCA). The 
catalytic triad of a β-CAs is perfectly conserved in all these enzymes (Figure 17). 
Moreover, VchCAβ showed all the characteristics of a classical β-CA: the two 
cysteines and one histidine amino, which are the amino acid residues responsible for 
the catalytic mechanism (Figure 17). 
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Figure 17. Multialignment of the amino acid sequences of the β-CA belonging to 
plants and bacteria, obtained with the ClustalW program, version 2.1. It was used the 
numbering system of Pisum sativum. The ligands of Zn(II) are shown in red. Legend: 
FbiCA, Flaveria bidentis, isoform I; PsaCA, Pisum sativum; PgiCAb, Porphyromonas 
gingivalis; BsuCA, Brucella suis; VchCAβ, Vibrio cholerae. 
 
5.3 VchCAγ 
VchCAγ is a CA belonging to γ class with a polypeptide chain of 184 amino acid 
residues. It shows an identity of 25-26% when compared with the two prototypes of 
the γ-CAs, CAM and CAMH, while presenting an identity of 38% when compared 
with PgiCA (γ-CA of Porphyromonas gingivalis). In figure 18 is shown the 
multialignment of VchCAγ with other bacterial γ-CAs identified in Porphyromonas 
gingivalis (PgiCA), Clostridium perfringes (CpeCA) and Methanosarcina 
termophila (CAMH and CAM). From figure 18 it is possible to see that VchCAγ 
retains the three histidines (His81, 117 and 122), responsible for the catalytic 
mechanism in all γ-CAs studied to date. 
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Figure 18. Multialignment of amino acid sequences of the γ-CA belonging to bacteria, 
achieved with the ClustalW program, version 2.1. It was used the numbering system of 
CAMH. The ligands of Zn (II) are shown in red. Legend: PgiCA, Porphyromonas gingivalis; 
CpeCA, Clostridium perfringes; CAMH, Methanosarcina temophila; CAM, Methanosarcina 
temophila; VchCAγ, Vibrio cholerae. 
 
5.4 Cloning sequencing and production of expression vector 
The three classes of CAs belonging to V. cholerae (VchCA, VchCAβ and 
VchCAγ) have been prepared using the DNA recombinant technology. The synthetic 
genes encoding for VchCA (657bp) or VchCAβ (669bp) or VchCAγ (552bp) were 
cloned into the expression vector pET-15b (see “Material and Methods”) 
 
5.5 Growing condition and recombinant protein production 
Time course experiments were performed to optimize the protein expression. For 
this propose, bacterial cells were transformed with the appropriate expression 
vectors, grown in rich medium and, after induction with IPTG and metal addition, 
samples were collected at various time points as described in the experimental 
section. Compute pI/MW program calculated a theoretical molecular weight of 25 
kDa for VchCA, of 29 kDa and 24 kDa for VchCAβ for VchCAγ. In this calculation 
was included also the His-Tag fragment. After the induction with IPTG, the SDS-
PAGE showed that most of protein present in the soluble fraction was obtained after 
5 hours for VchCA, 4 hours for VchCAβ and 6 hours for VchCAγ (data not shown).  
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Once defined the optimum growth conditions a bacterial culture of 2.0 L has 
been prepared by using the bacteria transformed with the construct of interest (pET-
15b/VchCA, pET-15b/VchCAβ, pET-15b/VchCAγ). Protein expression was 
performed as described in the experimental section and the bacterial pellet was 
resuspended in Tris-HCl 10 mM, pH 8.3 and disrupted by sonication. 
 
5.6 Purification  
The bacterial extract obtained by sonication was purified by Nichel affinity 
chromatography as described in “Materials and Methods”. The fractions containing 
the protein of interest were dialyzed against 10 mM Tris-HCl pH 8.3. The yield of 
the protein at the end of the purification process was 30 mg for VchCA and VchCAβ, 
while VchCAγ was recovered with a yield of about 0.7 mg. The recombinant 
proteins were analyzed by SDS-PAGE as shown in Figure 19.  
 
Figure 19. SDS-PAGE after affinity chromatography. Std: standards; 1: VchCA; 2: 
VchCAβ; 3: VchCAγ.  
 
 
5.7 Biochemical characterization 
5.7.1 Specific Activity 
The Vibrio CAs produced as described above were assayed in solution using 
CO2 as a substrate and following the procedure described by Chirica et al. Enzyme 
activity was expressed as Wilbur-Anderson units (WAU). Table III shows specific 
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activities of VchCA, VchCAβ and VchCAγ compared with those obtained for the 
bovine enzyme bCA (α-CA). The specific activity of VchCA is 5.4 times higher than 
the commercial bovine enzyme (bCA), 16 times greater than that calculated for 
VchCAβ and 8 times that of VchCAγ. The results obtained demonstrate that the 
VchCA (α-CA) was the most active. Interestingly VchCAγ, is more active than 
VchCAβ (respectively the γ-class and β-class CAs founded in V. cholerae genome). 
Generally, γ-CA are reported to be less active than β-CAs  
Table III. Specific activity of the three classes of CAs identified in the genome of V. 
cholerae and of bovine α-CA. 
 Class Specific activity 
(WAU/mg protein) 
VchCA α 26232 
VchCAβ β 1600 
VchCAγ γ 3200 
bCA α 4845 
 
As described in literature α-class CAs, in addition to the hydration reaction of 
CO2, catalyze such as secondary reaction the reversible reaction of hydrolysis of 
esters. The esterase activity of VchCA, identified in the genome of V. cholerae, was 
determined using as substrate the p-NpA. VchCA presents a very low esterase 
activity (19 U/mg) compared with that of the commercial bCA (Table IV).  
Table IV. Esterase activity of VchCA and bCA. 
 
Class Specific activity 
(WAU/mg protein) 
VchCA α 19 
bCA α 1100 
 
5.7.2 Kinetic constants 
In Table V are shown the rate constants (kcat, KM and kcat/KM) of the three classes of 
CA identified in the genome of V. cholerae and the inhibition constant (KI) using the 
inhibitor acetazolamide. These constants were compared with the kinetic parameters 
of other CAs belonging to α-, β- and γ-classes identified in different organisms and 
microorganisms. 
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Table V. Determination of the kinetic constants for the hydratase reaction catalyzed 
by CAs identified in the genome of V. cholerae. The results were compared with 
those obtained for CAs identified in other organisms. The inhibition constant (KI) 
was obtained for the classical sulfonamide inhibitor, acetazolamide. 
 
VchCA showed a kcat of 8.23 × 105 s-1, a KM of 11.7 mM and a kcat/KM of 7.0 × 
107 M-1 s-1. VchCA was more active of the human isoform hCAI (kcat = 2.0 × 105 s-1) 
and hpαCA (kcat = 2.5 × 105s-1), it has an activity of an order of magnitude lower than 
hCA II and SazCA, an extremophilic CA from the genome of Sulfurihydrogenibium 
azorense. Furthermore, VchCA was inhibited by acetazolamide (KI = 6.8 nM) better 
than the hCA II and hpαCA.  
VchCAβ had a kcat of 3.34 × 105s-1 and a KM of 8.1 × 10-3s-1and a catalytic 
efficiency of 4.1 × 107 M-1 s-1. The enzyme showed a kcat similar to that of the 
enzyme identified in plant (FbiCA1) and its catalytic efficiency is very similar to that 
of other bacterial enzymes, but it was two orders of magnitude lower compared to the 
β-class enzyme identified in the bacterium Porphyromonas gingivalis (PgiCAβ). In 
addition, acetazolamide was found to be a less effective inhibitor for VchCAβ than 
VchCA, showing an inhibition constant of 451 nM (Table V). 
VchCAγ showed a kcat of 7.39 × 105s-1, an order of magnitude higher than that of 
γ-CA (CAM) identified in the thermophilic Archeon Metanosarcina thermophila 
and, slightly higher than the kcat of the bacterial γ-CA PgiCA. Interestingly, VchCAγ 
resulted more active than VchCAβ, while the acetazolamide shows an inhibition 
constant of 473 nM. 
5.7.3 Thermoactivity and Thermostability 
Thermoactivity was only determined for VchCA because this is the unique class 
of CA (α-CA) that possesses an esterase activity. The results were compared with 
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those obtained for the bovine enzyme, bCA. In Figure 20 is shown that VchCA 
activity is shifted of 10 degrees respect to that of the mammalian enzyme. bCA, in 
fact, showed a maximum peak of enzyme activity at 60 °C, while for VchCA this 
peak was at 70 °C (Figure 20).  
 
 
Figure 20. Comparison of the thermoactivity of VchCA and bCA. The enzyme activity was 
measured at the indicated temperatures on the x-axis using the p-NpA as a substrate. Each 
point is the mean ± SEM of three independent determinations 
 
This variation may be due to the fact that the enzyme of Vibrio cholerae is 
characterized by an amino acid sequence shorter than bCA, which probably confers 
stability to the bacterial enzyme. 
Thermostability of VchCA, VchCAβ, VchCAγ and bCA were investigated 
incubating each enzyme at 30, 40, 50, 60, 70, 80 and 90 °C. After 30 and 120 
minutes of incubation, an aliquot of each enzyme was taken and assayed using CO2 
as a substrate. Figure 21 showed that after 30 minutes of incubation the activity of 
the bovine enzyme (bCA) decreases faster than that of VchCA. In fact, at 80 °C the 
residual activity for VchCA is 40%, while for bCA is 0. VchCAγ and VchCAβ have 
a behavior very similar to the bovine enzyme (Figure 21). After 120 minutes of 
incubation, bCA and VchCAβ are inactive at temperatures higher than 60 °C, 
VchCAγ is inactivated at 70 °C, while VchCA is completely inactive at 80 °C. These 
results demonstrated that VchCA is more stable respect to the β and γ-CAs identified 
in the genome of Vibrio cholerae. 
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Figure 21. Thermostability of VchCA, VchCAβ, VchCAγ and bCA. The enzymes were 
incubated for 30 to 120 minutes at the indicated temperatures on the x-axis and assayed 
using CO2 as a substrate. Each point is the mean ± SEM of three independent determinations. 
 
5.7.4 Protonography 
The activity of proteolytic enzymes, capable of refold and acquire the proteolytic 
activity after treatment with SDS, can be determined by SDS-PAGE after the 
removal of the detergent. Such a technique is known with the name of zymography. 
It has developed a technique to identify the activity of CA hydratase on SDS-PAGE 
(see Materials and Methods), we named this technique protonography, because 
during the CO2 hydratase reaction are produced protons, which are then responsible 
of the change of color that appears on the gel, in correspondence of the CA (see 
Material and Methods). In figure 22 are reported the protonograms obtained using 
the commercial bovine bCA (α-CA class) and the recombinant CAs (α, β and γ) from 
V. cholerae. Protonograms of VchCA, VchCAβ and VchCAγ showed the different 
behavior that the three bacterial CAs assumed during the SDS-PAGE. It is known 
that mammal α-CAs are monomeric and the protonogram of bCA showed a single 
band of activity corresponding to a monomer of 30 kDa (Figure 22 A). The bacterial 
α-CAs are generally dimeric enzymes and the protonogram showed three bands of 
activity: a monomer (25 kDa), a dimer (50 kDa) and a tetramer (100 kDa) (Figure 22 
A). Therefore, unlike bCA, VchCA is present in three different oligomeric states. 
The protonogram of VchCAβ (Figure 22 B) showed two bands of activity: a band 
corresponding to the monomeric form (29 kDa) and one at the dimeric form (58 
kDa). The protonogram of VchCAγ showed a band of activity in correspondence of 
the monomer (24 kDa) and the trimer (69 kDa) (Figure 22 C). The yellow bands 
found in correspondence of the inactive monomeric form of VchCAβ or VchCAγ, is 
due to the fact that at the end of the electrophoretic run, the SDS is removed from the 
gel. This procedure may lead to the rearrangement of β- or γ-CA monomers in the 
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gel and the final result is the reconstitution of the active dimeric (β -CA) or trimeric 
forms (γ -CA). Protonography allowed us to distinguish not only the active enzyme, 
but also oligomeric states of the CA.  
 
Figure 22. A: protonogram and SDS-PAGE stained with Coomassie compared. Both Gels 
were run in non-reducing denaturing conditions and loaded with 4 micrograms of bCA and 
VchCA. The appearance of the band occurred after 5 seconds of incubation in CO2 saturated 
water. B: protonogram of VchCAβ with a molecular weight marker (Coomassie gel not 
shown). The band appeared after 40 seconds of incubation in CO2 saturated water. C: 
protonogram of VchCAγ with a molecular weight marker (Coomassie gel not shown). The 
band appeared after 25 seconds of incubation in CO2 saturated water. 
 
5.8 Inibition 
5.8.1 Sulfonamides and the bioisosteres 
In collaboration with Prof. C. Supuran, University of Florence, a large number of 
sulfonamides and sulfamates were tested to evaluate their effectiveness on the 
inhibition of V. cholerae CA.  
Simple aromatic and heteroaromatic sulfonamides of types 1-24 were among 
them, as well as derivatives AAZ-IND, which are clinically used drugs or agents in 
clinical development (Figure 34). Acetazolamide AAZ, methazolamide MZA, 
ethoxzolamide EZA and dichlorophenamide DCP, are the classical, systemically 
acting CAIs. Dorzolamide DZA and brinzolamide BRZ are topically-acting 
antiglaucoma agents, benzolamide BZA is an orphan drug belonging to this class of 
pharmacological agents, whereas topiramate TPM and zonisamide ZNS are widely 
used antiepileptic drugs. Sulpiride SLP and indisulam IND were recently shown by 
this group to belong to this class of pharmacological agents. Sulfonamides 1-24 and 
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the clinically used agents investigated in this study were either commercially 
available, or were prepared as reported earlier by our group (Figure 23). 
The study of inhibition profiles has the aim to identify the existence of selective 
inhibitors for the CA identified in the genome of V. cholerae. Some of these 
compounds are excellent inhibitors of bacterial enzymes (Table VI). These results 
will be of great assistance for the realization of new inhibitors characterized by a 
high selectivity towards the bacterial CAs. 
 
 
Figure 23. Sulfonamides and bioisosteres inhibitors structures 
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Table VI.  Sulfonamides and bioisosteres inhibition constants for the human α-CA isoform I 
and II, the α-CA of H. pylori (hpαCA) and the three classes of CA identified in the genome 
of V. cholerae, obtained with the technique of "stopped flow" at 20 ° C and pH 7.5. 
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Table VI showed inhibition data for this panel of sulfonamides (and one sulfamate, 
TPM) against the human α-CAs (isoforms hCAI and hCAII) and the recombinant α, 
β and γ CAs from Vibrio cholera. The following should be noted regarding a 
comparison of V. cholerae enzymes inhibition with the compounds investigated in 
this study: Topiramate TPM, a sulfamate, sulpiride SLP, a primary sulfonamide, as 
well as saccharin SAC, an acylsulfonamide, were ineffective VchCA inhibitors 
(KIs>1000 nM). Moreover, SAC was a bad inhibitor for VchCAβ and VchCAγ, 
while TPM and SLP were effective inhibitors of VchCAγ. These compounds 
(except saccharin) generally act as good inhibitors of other bacterial or mammalian 
α-CAs. Zonisamide, ZNS, an aliphatic primary sulfonamide was also a very weak 
inhibitor for the bacterial enzymes but effective towards the human enzymes (KIs 
≥725 nM). A large number of simple aromatic sulfonamides, such as derivatives 1-9, 
showed moderate VchCA and VchCAγ inhibitory properties, with inhibition 
constants in the range of 125 – 672 nM (Table VI). It may be observed that all these 
derivatives are benzenesulfonamides with one or two simple substituents in ortho-, 
para- or the 3,4-positions of the aromatic ring with respect to the sulfamoyl zinc-
binding moiety. Most of these CAIs were ineffective towards VchCAβ with KIs ≥ 
9120 nM. Most of the sulfonamides investigated here showed a potent inhibitory 
effect against VchCA, VchCAβ and VchCAγ with inhibition constants in the range 
of 23.5 – 88.5 nM. These derivatives include compounds 13-15. It is interesting to 
note that compounds 10-13, 16-18, 21-24, DCP, VLX, SLT and HCT showed a 
potent inhibitory effect against VchCA. Some of them are effective towards VchCAβ 
or VchCAγ but never effective for all the three classes identified in the genome of V. 
cholerae (Table VI). Several very potent VchCA inhibitors were detected, such as 
compounds 14, 15, 19, 20, AAZ, MZA, EZA, DZA, BRZ, BZA, and IND, which 
showed KIs in the range of 0.59 – 12.1 nM (Table VI). Most of the sulfonamides used 
were effective inhibitors of VchCAγ but the KIs was always ≥ 69 nM. The inhibition 
profile of VchCA, VchCAβ or VchCAγ was different from that of the other bacterial 
or mammalian CAs investigated up until now, proving that probably it will be 
possible to design VchCA-,VchCAβ- or VchCAγ-selective inhibitors using the 
scaffold of leads detected here. 
5.8.2	Anions 
In addition to sulfonamides and bioisosteres, another class of CA inhibitors is 
represented by anions. In the table VII is shown the inhibition profile of VchCA, 
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VchCAβ and VchCAγ with a series of simple and complex inorganic anions in 
comparison with those obtained for the human isoforms (hCA I and II) and the 
bacterial enzyme of Helicobacter pylori (hpαCA). 
 
Table VII. Anions inhibition constants for the human α-CAs isoforms I and II, α-CA of H. 
pylori and the three classes of CA identified in the genome of V. cholerae, obtained with the 
technique of "stopped- flow "at 20 ° C and pH 7.5. 
KIa (mM) 
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Interestingly, the carbonate and bicarbonate are not very effective inhibitors for V. 
cholerae CA (KI = 3.0 to 8.2 mM). This result is in agreement with the fact that V. 
cholerae colonizes the upper part of the small intestine characterized by high 
concentrations of bicarbonate, in turn considered a potent inducer of the expression 
of the genes involved in the virulence of the pathogen. This is an example of 
evolutionary adaptation of the Vibrio CAs to the high concentrations of bicarbonate. 
Interesting, also for two human isoforms (hCAI and hCAII) carbonate and 
bicarbonate are not effective inhibitors (KI = 12-85 mM). In fact, these anions are 
present in the plasma at high concentrations. 
5.9 Tridimensional structure of VchCAβ  
In collaboration with Dr. Marta Ferraroni, University of Florence, it was determined 
the crystallographic structure of the VchCAβ. The X-ray structure of VchCA was 
solved by molecular replacement using the coordinates of the β-CA from E. coli. The 
X-ray crystal structure of this new enzyme was similar to the structures of the other 
β-CAs. As described in literature, X-ray crystallographic analysis of β-CAs revealed 
two distinct subtypes of this enzyme class based on active-site organization, denoted 
type I and type II β-CAs (Figure 24A). In the enzymes from P. sativum, M. 
thermoautotrophicum and M. tuberculosis Rv1284, the active-site zinc ion is 
coordinated by one histidine and two cysteine residues, with a fourth coordination 
site occupied by water or a substrate analogue (the so-called open conformation). In 
contrast, the other subclass of β-CAs, exemplified by the structures of the enzymes 
from H. influenzae, E. coli, P. purpureum and M. tuberculosis Rv3588c, has a unique 
zinc-coordination geometry in which the water molecule has been replaced by an 
aspartate side chain, forming a noncanonical CA active site (the closed 
conformation). The latter group of CAs (type II β-CAs) are characterized by little or 
no CO2 hydration activity at pH values less than 8.0, compared with the former 
group (type I  β-CAs) that shows catalytic activity at pH values from as low as 6.5 to 
greater than 9.0. Type II β-CAs also show highly cooperative pH-rate profiles and 
cooperative inhibition by HCO3-, whereas type I β-CAs are not inhibited by HCO3-
(Rowlett. et al, 2010).  
The X-ray crystal structure of this new enzyme was solved at 1.9Å resolution from a 
crystal that was perfectly merohedrally twinned, revealing a tetrameric type II β-CA 
with a closed active site in which the zinc is tetrahedrally coordinated to Cys42, 
Asp44, His98 and Cys101 (Figure 24B). The substrate bicarbonate was found bound 
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in a noncatalytic binding pocket close to the zinc ion (Figure 24C), as reported for a 
few other β-CAs, such as those from Escherichia coli and Haemophilus influenzae. It 
has already been observed that the binding of the bicarbonate ion to this noncatalytic 
site enforces a closed conformation of the active site in type II β-CA structures. 
 
A                                                 B                                     C 
  
Figure 24 A: Ribbon structure showing the tetrameric arrangement of VchCA; B: the 
active site of VchCA exhibiting a ‘closed’ configuration; C: the noncatalytic bicarbonate-
binding site.  
 
However, the alternative open configuration has not been observed in any type II β-
CA structure, regardless of the crystallization pH and the concentration of 
bicarbonate in the crystallization medium, but the kinetic data suggest that these 
enzymes adopt this conformation in order to function in a highly cooperative manner. 
The active form can be inferred from the crystal structures of type I β-CAs in which 
Asp44 is detached from the catalytic zinc ion and is hydrogen-bonded in a bidentate 
mode to Arg46. 
 
 
 
  
protein solution mixed with 1 ml reservoir solution and were
equilibrated against 100 ml precipitant solution. The concen-
tration of the protein was 10 mg ml!1 in 50 mM Tris pH 7.2.
Initial crystallization condition were found using the JCSG-
plus screen (Molecular Dimensions) and were optimized.
Diffraction-quality crystals grew within one week to approx-
imate dimensions of 0.2 " 0.2 " 0.3 mm from a solution
consisting of 8% PEG 8000, 8% ethylene glycol, 100 mM
HEPES pH 7.5. The crystals belonged to the primitive tetra-
gonal space group P41, with unit-cell parameters a = 84.09,
c = 316.38 A˚. The asymmetric unit contained two tetramers
(VM = 2.8 A˚
3 Da!1, solvent content 56.1%) related by pseudo-
translational symmetry. A native data set extending to a
maximum resolution of 1.9 A˚ was collected on the BM30A
beamline at ESRF, Grenoble, France using a ADSC Quantum
315r detector and a wavelength of 0.979 A˚. For data collection
a crystal of the enzyme was cooled to 100 K using a solution
consisting of 15% PEG 8000, 15% ethylene glycol, 100 mM
HEPES pH 7.5 as cryoprotectant. The data were processed
with XDS (Kabsch, 2010).
2.5. Structure determination and refinement
The structure was solved by the molecular-replacement
technique using MOLREP (Vagin & Teplyakov, 2010) with
the coordinates of the structure of !-carbonic anhydrase from
E. coli (PDB entry 2esf; Cronk et al., 2006) as a starting model.
The model was refined using REFMAC5 (Murshudov et al.,
2011) from the CCP4 suite (Winn et al., 2011). Manual
rebuilding of the model was performed using Coot (Emsley et
al., 2010). Solvent molecules were introduced automatically
using ARP/wARP (Lamzin et al., 2001). Refinement resulted
in R-factor and Rfree values of 0.183 and 0.238, respectively.
Data processing and refinement statistics are summarized in
Table 1. The stereochemistry of the final model was analyzed
with PROCHECK (Laskowski et al., 1993). The overall mean
B factor of the structure after refinement was 22.92 A˚2 for
water molecules and 22.49 A˚2 for all atoms. Protein coordi-
nates have been deposited in the Protein Data Bank (PDB
entry 5cxk). Structural figures were generated with the UCSF
Chimera package (Pettersen et al., 2004).
2.6. Merohedral twinning
The data set was initially processed in space group P422
with reasonable statistics (Rmerge = 8.3%). Molecular repla-
cement in space group P41212 provided a solution with a single
tetramer in the asymmetric unit, which was refined to an R
factor and Rfree of 0.23 and 0.27, respectively. Later it was
realised that the data had been collected from a crystal that
was almost perfectly merohedrally twinned. Thus, the data
were processed again in the lower symmetry tetragonal space
group.
A molecular-replacement solution was found in space group
P41 with two tetramers related by a pseudo-translation, which
was confirmed by a peak that was 20% of the origin peak at
(0.0, 0.15, 0.50) in the native Patterson map. No rotational
symmetry was detected in the self-rotation function in addi-
tion to that derived from the fourfold crystallographic axis
and the noncrystallographic 222 symmetry exhibited by one
tetramer subunit.
The possibility of twinning of the data was suggested by
analysis of the intensity distribution. The phenix.xtriage
module of PHENIX (Adams et al., 2002) was used to analyze
the data for twinning. The multivariate Z-score from the
L-test of PHENIX was well above the expected value of 3.5. A
high Z-score value indicates that the data differ significantly
from what is expected for untwinned data. The results of the
twinning tests and twinning law are shown in Supplementary
Table S1.
Thus, the twin-refinement option in REFMAC was used.
The R factor and Rfree decreased substantially at the stage in
which this option was introduced in the refinement. The
twinning fraction refined to a value of 0.49.
research papers
2452 Ferraroni et al. # Tetrameric type II !-carbonic anhydrase Acta Cryst. (2015). D71, 2449–2456
Figure 1
(a) Ribbon diagram showing a single subunit of the VchCA! structure.
The active-site zinc is also represented with its ligands. (b) Ribbon
diagram showing the tetrameric arrangement of VchCA!.
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of H. influenzae !- A, and a bica bonate ion bound in the
same position as in VchCA! has previously been found in two
crystal structures: one of !-CA from E. coli (PDB entry 2esf)
and another from H. influenzae (PDB entry 2a8d) (Cronk et
al., 2006). It is worth noting that in order to obtain these latter
structures the crystals were intentionally soaked in a solution
containing 100 mM NaHCO3 before data collection.
It has already been observed that the binding of the bicar-
bonate ion to this noncatalytic site enforces a closed confor-
mation of the active site in type II !-CA structures. In fact
bicarbonate expels the side chain of Val47, which causes
reorganization of the 44–48 loop and results in the disruption
of the Asp44–Arg46 dyad, allowing Asp44 to displace the zinc-
bound water and bind directly to the zinc ion. This state has
been c lled the T state or inactive state, and it was previously
foun o be present at acidic and neutral pH. However, the
alternative open configuration has not been observed in any
type II !-CA structure, regardless of the crystallization pH
and the concentration of bicar-
bonate in the crystallization
medium, but the kinetic data
suggest that these enzymes adopt
this conformation in order to
function in a highly cooperative
manner. The active form can be
inferred from the crystal struc-
tures of type I !-CAs in which
Asp44 is detached from the
catalytic zinc ion and is hydrogen-
bonded in a bidentate mode to
Arg46. Nevertheless, the active
form has been observed in two
mutants of H. influenzae (D44N
and P48S/A49P; Rowlett et al.,
2009; Hoffmann et al., 2015)
and in a thiocyanate inhibitor complex of M. tuberculosis
!-CA (Covarrubias et al., 2006).
The presence of a triad of residues formed by Trp39, Tyr181
and Arg64 has previously been recognized as fundamental for
the binding of bicarbonate to the noncatalytic site and is
strictly conserved in type II !-CAs. In contrast, the Trp–Arg–
Tyr triad is absent in all type I !-CAs. Furthermore, the
noncatalytic bicarbonate-binding site seems to be especially
evolved for this particular ion, as other isoelectronic ions such
as acetate or nitrate would not be able to achieve all of the
hydrogen-bonding interactions in which bicarbonate partici-
pates simultaneously. Thus, our findings reinforce the
hypothesis that the bicarbonate binding to a noncatalytic site
near the zinc ion is a distinctive feature of type II !-CAs and
plays a significant role in the functionality of this enzyme type.
3.2. Kinetic data
We have investigated the kinetic properties of VchCA! as a
catalyst for the hydration of carbon dioxide to bicarbonate at
pH 8.3, when presumably the active site of the enzyme should
be in the open state, i.e. with water or hydroxide as the fourth
zinc ligand. Data are reported in Table 2, in which we have
included, for comparison, kinetic data for other "- and !-class
CAs of various origins, such as the bacterial CA from the same
pathogen belonging to the "-class (VchCA; Del Prete, De
Luca, Scozzafava et al., 2014), but also the human main red
blood cell isoforms hCA I and II (Supuran, 2012; Khalifah,
1971), together with !-CAs from various pathogens, such as
Can2 from the fungus Cryptococcus neoformans, CaNce103
from Candida albicans, psCA3 from the bacterium Pseudo-
monas aeruginosa (Supuran, 2012; Pinard et al., 2015) and
PgiCA! from another bacterial pathogen, Porphyromonas
gingivalis (Del Prete, De Luca, Vullo et al., 2014). The CO2
hydration reaction was monitored with and without a catalyst
by a stopped-flow CO2 hydration assay at pH 7.5 for the
"-CAs and at pH 8.3 for the !-CAs. Inhibition data with the
clinically used sulfonamide acetazolamide are also given
(Khalifah, 1971).
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Table 2
Kinetic properties of the V. cholerae "-class (VchCA) and !-class (VchCA!) CAs for the CO2 hydration
reaction determined by a stopped-flow CO2 hydrase assay and their inhibition data with the clinically used
sulfonamide acetazolamide (Khalifah, 1971).
Kinetic/inhibition data for other "-class and !-class CAs are given for comparison. The measurements were
performed at pH 7.5 for the "-CAs and at pH 8.3 for the !-CAs. Can2, C. neoformans !-CA; CaNce103, C. albicans
!-CA; psCA3, P. aeruginosa !-CA, isoform 3 (Supuran, 2012; Pinard et al., 2015).
Enzyme Class kcat (s
"1)
kcat/Km
(M"1 s"1)
Ki (acetazolamide)
(nM) Reference
hCA I " 2.0 # 105 5.0 # 107 250 Supuran (2012)
hCA II " 1.4 # 106 1.5 # 108 12 Supuran (2012)
Can2 ! 3.9 # 105 4.3 # 107 10.5 Supuran (2012)
CaNce103 ! 8.0 # 105 9.7 # 107 132 Supuran (2012)
PgiCA! ! 2.8 # 105 1.5 # 107 214 Del Prete, De Luca, Vullo et al. (2014)
psCA3 ! 1.40 # 105 1.0 # 107 75.9 Pinard et al. (2015)
VchCA " 8.23 # 105 7.0 # 107 6.8 Del Prete, De Luca, Scozzafava et al. (2014)
VchCA! ! 3.34 # 105 4.1 # 107 4512 This work
Figure 4
The noncatalytic bicarbonate-binding site. A 2Fo " Fc electron-density
map (contoured at 1.5#) is also shown. Hydrogen bonds formed by the
bicarbonate ions to enzyme residues and water molecules are also
depicted as dashed lines.
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Chapter 6. Porphyromonas gingivalis CAs  
The microbiota of the human oral mucosa consists of a myriad of bacterial species 
that normally exist in commensal harmony with the host. Among the bacterial 
species living in the oral cavity, a bacterial complex named “red complex” and 
composed of Porphyromonas gingivalis, Treponema denticola, and Tannerella 
forsythia has been strongly associated with advanced periodontal lesion. 
Porphyromonas gingivalis is one of the few major pathogens responsible for the 
development of chronic periodontitis and a successful colonizer of the oral 
epithelium. The perturbation of epithelial cells by bacteria is the first stage in the 
initiation of inflammatory and immune processes causing eventually destruction of 
the tissues surrounding and supporting the teeth, which ultimately result in tooth loss. 
From the inspection of the P. gingivalis genome, carried out using the BLAST 
program, it was found that the pathogen encoded for two classes of carbonic 
anhydrase: the β-class CA, indicated with the acronym PgiCAb; the γ-CA, named 
PgiCA.  
 
6.1 PgiCAb (β-CA) 
The full nucleotide sequence showed an open reading frame encoding a 242 
residues polypeptide chain which contained all the typical features of a β-CA, 
including the three residues that are involved in the catalytic mechanism of the 
enzyme (two cysteines and one histidine, more precisely Cys90, His143 and Cys146, 
see Figure 25). Furthermore, the catalytic dyad (Asp92-Arg94) involved in the 
activation of the water molecule coordinated to the zinc ion from the enzyme active 
site, is also conserved in PgiCAb, as for the other investigated β-CAs such as the two 
enzymes from Legionella pneumophila lpCA1 and lpCA2, H. pylori enzyme, 
HpyCA, as well as the two β-CAs from Salmonella typhimurium, stCA1 and stCA2. 
 
	 55	
 
Figure 25. Amino acid sequences alignment of selected β-CAs from several bacterial 
species. The LpCA1 numbering system was used. Amino acid residues participating in the 
coordination of the metal ion are indicated in red and bold (Cys90, His143 and Cys146, 
respectively), whereas the catalytic dyad involved in the activation of the water molecule 
coordinated to zinc (Asp92–Arg94) is shown in blue and bold. The asterisk (*) indicates 
identity at a position; the symbol (:) designates conserved substitutions, whereas (.) indicates 
semi-conserved substitutions. The multiple sequence alignment was performed with the 
program MUSCLE and refined using the program Gblocks. Legend: PgiCAb, 
Porphyromonas gingivalis (YP_001929649.1); lpCA1, Legionella pneumophila, isoform 1 
(WP_014844650.1); lpCA2, Legionella pneumophila, isoform 2 (WP_014842179.1); 
HypaCA, Helicobacter pylori (YP_005769368.1); stCA1, Salmonella typhimurium, isoform 
1 (NP_459176.1); stCA2, Salmonella typhimurium, isoform 2 
 
6.2 PgiCA (γ-CA) 
The open reading frame of the P. gingivalis gene encodes a 192 amino acid 
polypeptide chain, which displays 33% and 30% identity when compared with the 
prototypical γ-CAs CAM and CAMH, respectively (Figure 26). CAM and CAMH 
both belong to the γ-CA class and were isolated from the Archaeon Methanosarcina 
thermophila; they have been thoroughly characterized by Ferry’s group (A.	Zimmerman., et al., 2009) 
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Figure 26. Amino acid sequence alignment of the γ-CAs: PgiCA, CAMH and CAM. The 
metal ion ligands (His81, His117 and His122) are indicated in red; the catalytically relevant 
residues of CAM, such as Asn73, Gln75 and Asn202 which participate in a network of 
hydrogen bonds with the catalytic water molecule, are indicated in green; the acidic loop 
residues containing the proton shuttle residues (Glu84) is also colored in green, but it is 
missing in CAMH and PgiCA (CMA numbering system). The asterisk (*) indicates identity 
at all aligned positions; the symbol (:) relates to conserved substitutions, while (.) means that 
semi-conserved substitutions are observed. The multialignment was performed with the 
program Clustal W. 
 
 
Data of Figure 26 show that the three His residues involved in the Zn(II) 
coordination (His81, 117 and 122, CAM numbering system) are conserved in PgiCA, 
similar to all other γ-class CAs studied. In the γ-CAs, or at least for CAM, the 
residue acting as a proton shuttle seems to be a glutamic acid (Glu84). The results of 
Ferry’s group suggest that the majority of the γ class CAs belong to a subclass of 
proteins distinct from CAM, probably more related to CAMH. Furthermore, the 
catalytic activity of many of these proteins is uncertain or anyhow, poorly 
investigated at this moment. The analysis of the amino acid sequence of CAM, 
CAMH, and PgiCA, suggest that PgiCA is more similar to CAMH than CAM. 
 
6.3 Cloning, expression and purification of PgiCAb and PgiCA 
The two classes of CAs belonging to P. gingivalis (PgiCAb and PgiCA) have been 
prepared using the DNA recombinant technology. The synthetic genes encoding for 
PgiCA (588 bp) or PgiCAb (741 bp) were cloned into the expression vector pET-15b 
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(see “Material and Methods”). Once defined the optimum growth conditions a 
bacterial culture of 2.0 L was prepared to produce PgiCAb and PgiCA. At the end of 
the purification procedure the two recombinant proteins were analyzed by SDS-
PAGE. The enzymes were at least 90% pure as shown in Figure 27.  
 
                 STD                PgiCAb (β-CA)                        STD             PgiCA (γ-CA)  
 
 
 
 
 
Figure  27. SDS-PAGE after affinity chromatography. Legend: Std, standards; PgiCA, γ-
CA; PgiCAb, β-CA 
 
6.4 Biochemical characterization 
6.4.1 Determination of oligomeric state 
Analysis by SDS-Page of PgiCAb showed two main bands of about 25 kDA 
(monomeric form) and 50 kda (dimeric form) under reducing condition, while PgiCA 
showed a single band of about 22kDA. PgiCA was subject to a HPLC gel-
permeation chromatography under native conditions to determine the oligomeric 
state of the protein. PgiCA was eluted from the gel-filtration column as a protein 
with an estimated molecular mass of 65 kDa (Figure 28). Given a calculated subunit 
molecular mass of 20.8 kDa, these results suggest that the recombinant enzyme self-
associate in a homotrimer. This is in agreement with Ferry’s studies on the γ-class 
CA. The carbonic anhydrase from the thermophilic methanoarchaeon 
Methanosarcina thermophila, CAM, is the prototype of the γ-class and the only γ-
CA that has been characterized. CAM showed a homotrimer structure with an 
approximate molecular mass of 70 kDa (data reported by Ferry’s group). 
 
25 kDa 
20 kDa 
50 kDa 
25 kDa 
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Figure 28.  Size exclusion chromatography column of the purified PgiCA enzyme carried 
out by HPLC. Dialyzed fractions from the His-tag affinity column chromatography step were 
concentrated and chromatographed on a BioSep-SEC-s2000 column (300 × 4.6 mm). The 
elution profile has been reordered at 280 nm. The peak at the retention time of 8.067 min 
corresponds to a MW of 65.4 kDa. The three points calibration curve indicated in the insert 
has been obtained using as standards the rabbit aldolase, the chicken egg albumin and the 
bovine cytochrome C (12.5 kDa). 
 
 
6.4.2 Kinetics constants 
Using the stopped-flow techniques and CO2 as a substrate, the kinetic parameters 
were determined for the purified recombinant PgiCAb and PgiCA. PgiCAb showed a 
significant catalytic activity, with a kcat of 2.8 x105 s-1 and a kcat/Km of 1.5 x 107 M-1 
x s-1. PgiCA showed a kcat of 4.1 x 105 and a kcat/Km of 5.4 x 107 M-1 x s-1 (Table 
VIII).  
 
Table  VIII . Kinetic parameters for the CO2 hydration reaction catalyzed by various 
CAs belonging to the various families. Inhibition data with the clinically used 
sulfonamide acetazolamide (5-acetamido-1,3,4-thiadiazole-2-sulfonamide) are also 
provided. All data were obtained in similar conditions. 
 
 
 
 
 
 
 
 
sulfonamides, sulfamates, phenols and dithiocarbamates17. These
studies evidenced the inhibition of bacterial growth in vivo,
providing proof-of-concept data that bacterial CAs represent very
promising targets for obtaining antibacterials devoid of the
resistance problems of the clinically used agents. Further studies
are however needed to validate these and other less investigated
enzymes as drug targets. In addition, only a very limited number
of bacterial genomes have been thoroughly examined for the
presence of CAs. It is thus obvious that PgiCAb inhibition studies
are needed in order to detect even stronger inhibitors, and
eventually the role that this enzyme plays in the pathogenesis of
P. gingivalis infection.
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Figure 3. Multi-alignment of the amino acid sequences of the selected b-CAs from plant, yeast, algae and bacterial organisms. Zinc ligands are
indicated in red, catalytic dyad in blue. The asterisk (*) indicates identity at a position; the symbol (:) designates conserved substitutions, while (.)
indicates s mi- onserved substitutions. Multiple alignment was performed with the program Clustal W, version 2.1. Legend: PgiCAb_bacterium,
Porhyromonas gingivalis (Accession number: YP_001929649.1); BsuCA_bacterium, Brucella suis (Accession number: WP_012243428.1);
HpyCA_bacteriu , Helicobacter pylori (Accession number: BAF34127.1 ; CspCA_alga, Coccomyxa sp. (Accession number: AAC33484.1);
SceCA_yeast, Saccha omyces cerevisiae (Accession number: GAA26059); DbrCA_yeast, Dekkera bruxellensis AWRI1499 (Accession number:
EIF49256); SpoCA_yeast, Schizosaccharomy es pombe (Access on number: CAA21790); FbiCA_plant, Flaveria bidentis, isoform I (Accession
number: AAA86939.2); ZmaCA_plant; Ze mays (Accession number: NP_001147846.1).
Figure 4. Phylogenetic tree of the b-CAs used in the multi-alignment
showed in Figure 3. The tree was constructed using the program PhyML
3.0. Branch support values are reported at branch points. For the legend
see Figure 3.
Table 1. Kinetic parameters for the CO2 hydration reaction catalyzed by
various CAs belonging to the various families.
Isozyme Class Organism
kcat
(s!1)
kcat/Km
(M!1" s!1)
KI (acetazolamide)
(nM)
SspCA a Bacterium 9.35" 105 1.1" 108 4.5
SazCA a Bacterium 4.4" 106 3.5" 108 0.9
Can2 b Fungus 3.9" 105 4.3" 107 10.5
FbiCA1 b Plant 1.2" 105 7.5" 106 27
PgiCAb b Bacterium 2.8" 107 1.5" 107 214
PgiCA ! Bacterium 4.1" 105 5.4" 107 324
CAM ! Archaeon 6.1" 104 8.7" 105 63
Inhibition data with the clinically used sulfonamide acetazolamide
(5-acetamido-1,3,4-thiadiazole-2-sulfonamide) are also provided. All
data were obtained in similar conditions (see Materials and Methods for
details).
4 S. Del. Prete et al. J Enzyme Inhib Med Chem, Early Online: 1–5
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In Table VIII is reported the comparison of the kinetic parameters of PgiCAb and 
PgiCA with other CAs belonging to different family and from different organisms. 
SazCA (α-CA) from the extremophilic bacterium Sulfurihydrogenibium azorense 
resulted the faster CAs known to date, i.e. showed a kcat of 4.4 x106 s-1; whereas the 
β- and γ-CAs showed kinetic constants ranging from 104 to 105 s-1. Interestingly, in 
general the catalytic efficiency of the γ-CAs is lower compared to the β-CAs, which 
in turn are also less efficient catalysts compared to many bacterial α-CAs (Table 
VIII). However, PgiCAb is about 2.3 times faster than the β-CA isolated from 
Flaveria bidentis but 1.5 times slower when compared with the γ-class enzyme 
PgiCA. It may also be observed that the CO2 hydrase activity of PgiCAb is inhibited 
by the clinically used sulfonamide acetazolamide, with an inhibition constant of 214 
nM. Enzyme kinetic analysis showed that PgiCA is 62 times more effective as a 
catalyst compared to CAM, the only other γ-CA characterized in detail kinetically 
(Vullo., et al. , 2013). It has been noted that the enhanced efficiency of PgiCA 
compared to CAM is due both to the fact that the kinetic rate constant of the P. 
gingivalis enzyme is 6.7 times higher compared to that of the archaeal enzyme, as 
well as because the Km of the PgiCA is much lower (around 7.5 mM) compared to 
the one of CAM (around 70 mM). Thus, the enhanced catalytic efficiency of PgiCA 
compared to CAM is due to both kinetic (higher kcat) and thermodynamic factors 
(lower Michaelis-Menten constant for the binding of the substrate within the active 
site of the enzyme). It was also noted that PgiCA is more active catalytically than 
other α- or β-CAs, such as hCA I (human isoform), Can2 (fungal enzyme), FbiCA 
(plant enzyme), being only slightly less efficient compared to hCAII, a highly 
effective catalyst for the CO2 hydration reaction together with SspCA and SazCA. 
 
6.4.3 Thermostability of PgiCA 
It has been investigated the effect of the temperature on the stability of PgiCA. The 
enzyme stability was studied in the 25 – 90 °C temperature range incubating the 
enzyme for 10, 30, 60 and 120 min (Figure 29). After 10, 30, 60 and 120 min of 
incubation, enzyme activity was determined using CO2 as substrate. Interesting, the 
enzyme was stable up to 80 °C when the incubation time did not exceed the 30 
minutes. As shown in Figure 28, the residual activity at this incubation time and 80 
°C is still 35 %, and starts to decline at 15 and 0 % when the incubation time is 60 
and 120 min, respectively. However, when the incubation time is 120 min the 
enzyme is completely inactivated. 
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Figure 29.  Thermostability of PgiCA. The enzyme was incubated at 25, 40, 50, 60 70, 80 
and 90 °C for 10, 30, 60 and 120 and assayed using CO2 as substrate. 
 
 
6.5 Inhibition studies 
 
6.5.1 PgiCA (γ-CA) 
a) Sulfonamide inhibition  
A library of 40 compounds, comprising 39 sulfonamides and one sulfamate were 
included in our study. Data of Table IX show the inhibition data of PgiCA with the 
40 derivatives mentioned above. Inhibition data of the human (h), possibly off target 
isoforms hCA I and II, of a β-class CA, LdcCA (from the protozoan pathogen 
Leishmania donovani chagasii) and of CAM, the only other γ-CA investigated in 
detail, are also presented in Table IX. A large number of compounds, among which 
1, 3, 5, 6, 12, 20–24, DCP, and TPM were weak PgiCA inhibitors (KIs in the range 
of 1.035–4.65 lM) or were totally ineffective against this enzyme (compound 3 and 
TPM has inhibition constants of >100 lM). It may be observed that apart the sugar 
sulfamate TPM, most other compounds are simple benzenesulfonamides 
incorporating small, compact moieties such as amino, aminoalkyl, halogeno, etc., 
Compounds 20–24 on the other hand are aromatic/ heterocyclic sulfonamides 
incorporating arylsulfonylamido moieties, possessing thus a rather elongated 
molecule. The best inhibitory power against PgiCA among the investigated 
sulfonamides was observed for the following derivatives: 9, 10, 15–17, AAZ, MZA, 
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ZNS, IND, CLX, SAC and HCT, which showed inhibition constants in the range of 
131–380 nM (Table IX). 9 and 10 are benzenesulfonamides incorporating amino and  
Table IX Inhibition of human isoforms hCA I and hCA II, of the protozoan 
one from L. donovani chagasi (LdcCA) as well as the bacterial enzyme from 
Metanosarcina thermophila (CAM) and Porphyromonas gingivalis (PgiCA) 
with sulfonamides 1–24 and the clinically used drugs AAZ—HCT, by a CO2 
hydrase, stopped-flow assay 
 
 
halogen or OH and halogen groups, and these substitution patterns greatly increase 
the PgiCA inhibitory power compared to the sulfanilamide lead 2, which is a rather 
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ineffective inhibitor of this enzyme (Table IX). Interestingly, 15–17 are also quite 
simple benzenesulfonamide derivatives, incorporating 4- OH, 4-hydroxymethyl and 
4-hydroxyethyl moieties, and their inhibition constants (in the range of 178–326 nM) 
are much better compared to the corresponding amino-derivatives 2, 5 and 7 (KIs of 
893–3840 nM, Table IX) Dichlorophenamide, topiramate and many simple 
aromatic/heterocyclic sulfonamides were ineffective as PgiCA inhibitors whereas the 
best inhibition was observed with halogenosulfanilamides incorporating heavy 
halogens, 4-hydroxy- and 4-hydroxyalkyl-benzenesulfonamides, acetazolamide, 
methazolamide, zonisamide, indisulam, celecoxib, saccharin and hydrochlorothiazide 
(KIs in the range of 131– 380 nM). The inhibition profile of PgiCA was very 
different from that of CAM, hCA I and II or the β-CA from a protozoan parasite. 
 
b) Anion inhibition study 
We have also investigated the inhibition profile of the new enzyme with a range of 
inorganic anions as well as other small molecules known to interact with zinc 
enzymes, such as sulfamide, sulfamic acid, boronic and arsonic acids (Table X). 
Both simple, inorganic anions such as halides, pseudohalides, bicarbonate, carbonate, 
sulfate (and anions isoelectronic with them) as well as complex inorganic anions 
were included in our study. Inhibition data of the human predominant isoform 
(hCAII, α-class) and CAM (γ-class, when available) are also reported in Table X, for 
comparison reasons. Perchlorate and tetrafluoroborate did not inhibit appreciably 
PgiCA. In fact these two anions were generally noninhibitory against most CAs 
(belonging to all genetic families) investigated so far, probably due to their relatively 
low affinity for metal ions (compared to most other complexing anions). Weak 
PgiCA inhibition has been observed with selenate, tellurate, diphosphate, divanadate, 
tetraborate and fluorosulfonate, which showed inhibition constants in the range of 
18.5–89.5 mM. Another group of ineffective PgiCA inhibitors (but better ones 
compared to those mentioned above) included iodide, nitrate, nitrite, hydrogensulfite, 
sulfate, stannate, perruthenate, peroxydisulfate and iminodisulfonate, which showed 
inhibition constants in the range of 3.1–10.8 mM (Table X). The following anions 
showed submillimolar inhibition of PgiCA: fluoride, chloride, bromide, cyanate, 
bicarbonate, carbonate, perrhenate, and selenocyanide. These anions possessed KIs in 
the range of 0.71–0.96 mM. It should be noted that in the halides series, the first 
three (light) halides showed a rather similar, submillimolar affinity for PgiCA, 
whereas iodide was a rather weak inhibitor. This is very different from the situation 
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observed for hCA II for which the inhibition increased with the atomic weight of the 
halogen, or for CAM, for which fluoride and chloride were not at all inhibitory 
whereas bromide and iodide were very weak inhibitors (Table X). 
 
Table X Inhibition constants of anionic inhibitors against the h-CA 
(human) isoform hCAII, and the γ-CAs, Zn-CAM and PgiCA, for the 
CO2 hydration reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Several of the investigated anions and small molecules showed efficient or very 
efficient inhibition of the PgiCA activity, with inhibition constants in the range of 
4.0–97 M (Table X). They include thiocyanate, cyanide, azide, hydrogensulfide, 
trithiocarbonate, diethyldithiocarbamate, sulfamide, sulfamate, phenylboronic acid 
and phenylarsonic acid. It can be observed that the pseudohalides (thiocyanate, cya- 
Data of Figure 1 shows that the three His residues involved in
the Zn(II) coordination (His81, 117 and 122, CAM numbering sys-
tem) are conserved in PgiCA, similar to all other c-class CAs studied
so far. However, there are still some poorly understood aspects of
the catalytic cycle of the c-CAs, related to the proton transfer res-
idue which generates the nucleophilic, catalytically active species
of the enzyme (i.e., with a hydroxide ion coordinated to the Zn(II)
ion). In -CAs this step is assisted by a His residue, whereas in
the -class enzymes a catalytic dyad constituted of an Asp–Arg pair
(conserved in all such enzymes studied so far) participates in gen-
erating the zinc hydroxide form of the enzyme.7,8,23,25 In the c-CAs,
or at least for CAM, the residue acting as a proton shuttle seems to
be a glutamic acid (Glu84), probably in its anionic form, as gluta-
mate. However, at the level of primary structure, there are net
differences between CAM and CAMH (the second c-CA identified
by Ferry’s group in M. thermophila),22 which are outlined here:
(a) the presence of an acidic loop which contains the proton shuttle
residue (identified as the first glutamic acid residue of the amino
acid sequence of the loop, as shown in Figure 1 and mentioned
above), which is present in CAM but not in CAMH; (b) an additional
N-amino terminal residue with characteristics of the signal pep-
tides in secretory proteins is present in CAM (but not CAMH), sug-
gesting that this enzyme is located outside the cytoplasmic
membrane.
The results of Ferry’s group suggest that the majority of the c
class CAs belong to a subclass of proteins distinct from CAM, prob-
ably more related to CAMH. Furthermore, the catalytic activity of
many of these proteins is uncertain or anyhow, poorly investigated
at this moment.22,29 The analysis of the hallmark characteristic of
CAM, CAMH and PgiCA presented above, suggest that PgiCA is
more similar to CAMH than CAM, as predicted by Ferry.22,29 Hence,
we have constructed a phylogenetic tree including most c-CAs se-
quences available from Archaea, Bacteria and plants, in order to
better understand the relationships of the P. gingivalis enzyme with
those of different other c-CAs (Fig. 2). Data of Figure 2 shows that
the P. gingivalis enzyme clustered in a branch distinct from that of
CAMH and CAM, which also appeared well separated from the
other clusters of Figure 2. It seems that PgiCA is more related to
the algal c-CAs than to the Archaeal or plant ones. This is in fact
also to be expected considering the much higher catalytic activity
of PgiCA compared to CAM or even CAMH.22 In other words, appar-
ently, PgiCA belongs to a distinct subclass of c-CAs compared to
CAM and CAMH. Mentioned should be made however that very
few such enzymes were investigated in detail (for their kinetic
properties or by means of X-ray crystallography for determining
thei 3D structu e).29
We have also investigated the inhibition profile of the new en-
zyme with a range of inorganic anions as well as other small mol-
ecules known to interact with zinc enzymes, such as sulfamide,
sulfamic acid, boronic- and arsonic acids7,27–29 (Table 2). Both
Figure 2. Phylogenetic trees of the amino acid sequences of c-CAs from different
sources (archaea, bacteria and plants). The tree was constructed using the program
PhyML 3.0. Legend: CreCA, Chlamydomonas reinhhardtii; EhuCA, Emiliania huxleyi;
AthCA, Arabidopsis thaliana; SlyCA, Solanum lycopersicum; PgiCA, Porphyromonas
gingivalis; CAM and CAMH, Methanosarcina thermophila.
Table 2
Inhibition constants of anionic inhibitors against the -CA (human) isoform hCA II, and
the c-CAs Zn-CAM and PgiCA, for the CO2 hydration reaction, at 20 !C26
Inhibitor KI [mM]b
hCA II Zn-CAM PgiCA
F! >300 >200 0.95
Cl! 200 >200 0.94
Br! 63 60 0.92
I! 26 160 8.7
CNO! 0.03 0.09 0.71
SCN! 1.6 7.0 0.093
CN! 0.02 0.68 0.041
N!3 1.5 5.8 0.073
HCO!3 85 42 0.96
CO2!3 73 6.7 0.89
NO!3 35 36.5 8.5
NO!2 63 6.8 3.1
HS! 0.04 0.05 0.092
HSO!3 89 11.7 9.3
SO2!4 >200 >200 8.7
SnO2!3 0.83 nt 10.8
SeO2!4 112 nt 85.5
TeO2!4 0.92 nt 16.7
P2O4!7 48.50 nt 78.9
V2O4!7 0.57 nt 18.5
B4O4!7 0.95 nt 71.6
ReO!4 0.75 nt 0.93
RuO!4 0.69 nt 5.3
S2O2!8 0.084 nt 8.7
SeCN! 0.086 nt 0.91
CS2!3 0.0088 nt 0.097
Et2NCS!2 3.1 nt 0.004
ClO!4 >200 nt >200
BF!4 >200 nt >200
FSO!3 0.46 nt 89.5
NHðSO3Þ2!2 0.76 nt 7.7
H2NSO2NH2 1.13 nt 0.0092
H2NSO3H 0.39 nt 0.093
Ph–B(OH)2 23.1 nt 0.0098
Ph–AsO3H2 49.2 nt 0.090
aAs sodium salt; nt = not tested.
b Errors were in the range of 3–5% of the reported values, from three different
assays.
Table 1
Kinetic parameters for the CO2 hydration reaction catalyzed by the human cytosolic isozymes hCA I and II (-class CAs) at 20 !C and pH 7.5 in 10 mM HEPES buffer and 20 mM
Na2SO4, the -CAs Can2, (from the fungal pathogen Cryptococcus neoformans), the plant Flaveria bidentis CA (FbiCA 1) and the c-CAs CAM (Methanosarcina thermophila) and PgiCA (P.
Gingivalis) measured at 20 !C, pH 8.3 in 20 mM TRIS buffer and 20 mM NaClO4.26 Inhibition data with the clinically used sulfonamide acetazolamide (5-acetamido-1,3,4-
thiadiazole-2-sulfonamide) are also provided
Isozyme Activity level Class kcat (s!1) kcat/Km (M!1 $ s!1) KI (acetazolamide) (nM)
hCA I Moderate a 2.0 $ 105 5.0 $ 107 250
hCA II Very high a 1.4 $ 106 1.5 $ 108 12
Can2 Moderate b 3.9 $ 105 4.3 $ 107 10.5
FbiCA 1 Low b 1.2 $ 105 7.5 $ 106 27
CAM Low c 6.1 $ 104 8.7 $ 105 63
PgiCA Moderate c 4.1 $ 105 5.4 $ 107 324
S. Del Prete et al. / Bioorg. Med. Chem. Lett. 23 (2013) 4067–4071 4069
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nide, azide) were much more active compared to the halides and cyanate (KIs in the 
range of 41–93 M for the first group versus 0.71–8.7 mM for the second one). 
Hydrogensulfide and trithiocarbonate also had a similar activity (KIs of 92– 97 M) 
whereas diethyldithiocarbamate was a highly effective PgiCA inhibitor, with an 
inhibition of 4.0 M (this was the best inhibitor detected in this study, apart 
acetazolamide). It is also interesting to note that sulfamide was an effective PgiCA 
inhibitor (KI of 9.2 M) whereas the structurally related sulfamic acid was around 10 
times a weaker PgiCA inhibitor (KI of 93M). The same situation was observed for 
the pair phenylboronic acid/phenylarsonic acid, with the first compound being an 
efficient (KI of 9.8 M) and the second one a less efficient (KI of 90 M) PgiCA 
inhibitor. The inhibition profile of PgiCA is very different from that of CAM (the 
only other γ-CA investigated in some detail regarding its inhibition with various 
classes of compounds) or hCA II (which belongs to the α-class). This is a very 
encouraging finding, if one considers the fact that PgiCA was cloned from an 
important human pathogen and it should be targeted specifically without interference 
with the host enzymes. 
 
6.5.2 PgiCAb (β-CA) 
Anion inhibition study  
We investigated the anion inhibition profile of the new enzyme with simple and 
complex anions, as well as small molecules inhibiting other CAs, among which 
(Table XI). Perchlorate, tetrafluoroborate, azide, nitrate, hydrogensulfite and 
sulfate were not inhibitors of PgiCAb, a behavior observed with most other α-, β- 
and γCAs investigated so far, for the first two anions, but for sure not for the last 
ones, which are rather effective inhibitors for other enzymes. For example azide has 
an inhibition constant of 73 µM against PgiCA and of 1.5 mM against hCA II, but it 
is not at all inhibitory against PgiCAb. A rather large number of anions, among 
which the halides, cyanide, bicarbonate, nitrite, selenate, diphosphate, divanadate, 
tetraborate, peroxodisulfate, hexafluorophosphate and triflate, were weak PgiCAb 
inhibitors with inhibition constants in the range of 5.4–21.4 mM. Interestingly, for 
the halogenides the fluoride and chloride had a similar behavior (KIs of 7.5–7.8 mM) 
whereas the heavier halogenides were weaker inhibitors (KIs of 15.9–21.4 mM). 
Usually the opposite is true, with the heavier halogenides being inhibitorier than the 
light ones (e.g., for hCA II and other α- or β-class CAs). It is also interesting to note 
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the difference of inhibitory power between bicarbonate (KI of 7.3 mM) and carbonate 
(KI of 3.7 mM), as these anions are in equilibrium with CO2, the substrate 
Table XI Inhibition constants of anionic inhibitors against the α-CA (human) 
isoform hCA II, the γ-CAs PgiCA (Porphyromonas gingivalis), and the β-class 
enzyme PgiCAb (Porphyromonas gingivalis), for the CO2 hydration reaction. 
 
of the enzyme. An even higher difference was observed between the very similar 
nitrate/nitrite, with the first one non-inhibitory and the second one with a KI of 7.8 
mM. Another group of anions, such as thiocyanate, carbonate, hydrogensulfide, 
stannate, tellurate, perrhenate, perruthenate, selenocyanide, trithiocarbonate, 
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fluorosulfonate and iminodisulfonate, were better PgiCAb inhibitors compared to 
anions discussed above, with inhibition constants in the range of 1.9–4.5 mM. Even 
more powerful inhibitors were on the other hand cyanate and diethylditiocarbamate, 
which had KIs of 0.23–0.76 mM. The most efficient PgiCAb inhibitors detected so 
far were sulfamide, sulfamate, phenylboronic acid and phenylarsonic acid, with KIs 
ranging between 60 and 78l M. It is also interesting to note that all these compounds 
are also effective inhibitors of the γ-class enzyme from this bacterium, PgiCA, being 
by far less efficient hCA II inhibitors. Thus, even this preliminary study was able to 
detect leads with a good inhibitory power against the two pathogenic bacterium 
enzymes, and also with a good selectivity for the pathogenic over the host enzyme 
inhibition. The inhibition profile of PgiCAb is generally quite different from that of 
PgiCA as well as the human isoform hCA II 
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Chapter 7. Plasmodium falciparum CAs  
In 2004, in genome of the protozoan Plasmodium falciparum, the causative agent 
of malaria Krungkrai and coworkers identified a gene encoding for a CA. This gene 
was identified in the GeneBank with the following accession number AAN35994.2. 
The open reading frame of the malarial CA enzyme (P. falciparum CA, accession 
number AAN35994.2, PlasmoDB: PF3D7_1140000) encodes a 600 amino acid 
polypeptide chain. In 2004, Krungkrai and coworkers cloned a truncated form of 
Plasmodium falciparum CA gene (GenBank: AAN35994.2) encoding for an active 
CA (named PfCA1) with a primary structure of 235 amino acid residues 
(Reungprapavut S., et al. 2004). The metalloenzyme showed a good esterase activity 
with 4-nitrophenylacetate as a substrate and was inhibited by known sulfonamide CA 
inhibitors (CAIs). The authors observed that the highly conserved α-CA active site 
residues, responsible for binding of the substrate and for catalysis, were present also 
in PfCA1 and considered thus the Plasmodium enzyme belonging to the α-CA class. 
Subsequent, it was showed that different Plasmodium spp. encoded CAs, all 
considered to belong to the α-class, and that primary sulfonamides inhibited in vitro 
and in vivo the growth of Plasmodium parasites. Recently, in the laboratory where I 
did my PhD, it was reanalyzed and realigned the amino acid sequence of the 
truncated PfCA1with the two human α-CA isoforms, hCAI and II, in order to 
identify other features of the protozoan enzyme (Figure 9). We observed that to have 
three histidines aligned with the three zinc-coordinating histidines of the human 
isoforms, it was necessary to ‘‘force’’ the alignment, introducing in the PfCA1 
sequence a five-residues insertion and a six-residues deletion between residues 96–
119. Nevertheless, the other residues crucial for the catalytic mechanism of the α-
CAs, such as the proton shuttle His64 and one of the gatekeeper residues, Thr199, 
seemed to be not conserved in the Plasmodium enzyme (Del Prete S. et al. 2014; 
Vullo D. et al. 2015; Supuran C.T. & Capasso C. 2014) (Figure 9). The dyad 
Glu106-Thr199 is highly conserved in all α-CAs investigated so far, being involved 
in the orientation of the substrate for the nucleophilic attack by the zinc hydroxide 
species of the enzyme. Thus, the proposed alignment showed important amino acid 
substitutions that differentiated the sequence of Plasmodium enzyme from those of 
other α-CAs. Hence, a phylogenetic tree was constructed to better investigate the 
relationship of the Plasmodia amino acid sequences with CAs from prokaryotic and 
eukaryotic species belonging to different classes (α-, β-, γ-, δ-, and ζ-CAs). In Figure 
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30 has been represented only the branches with α-, δ-, η and ζ-CAs). It was observed 
that Plasmodia CAs clustered in a branch different from that of the α-CAs, although 
close to it, while they were well separated from the other CA classes (Figure 30). We 
hypothesized that the Plasmodia CAs were the result of modifications of an ancestral 
δ-CA gene, which originated a new class of CA that we denominated η-class. 
 
 
 
Figure 30. Phylogenetic tree that led to the discovery of η class in the genus Plasmodium, 
built using the amino acid sequences of the α-, β-, γ-, δ-, ζ- and η-CA of prokaryotic and 
eukaryotic organisms. To build the tree was used PhyML 3.0 program. 
 
In collaboration with Dr. Giuseppina De Simone, we constructed, for homology 
modeling, the three-dimensional structure model of P. falciparum CA, aligning the 
entire shape of the CA of the protozoan (600 aa) with different amino acid sequences 
of α-CA with known crystallographic structure (De Simone G., et al. 2015) such as 
Neisseria gonorrhoeae, Thermovibrio ammonificans, Homo sapiens, 
Chlamydomonas reinhardtii, Aspergillus oryzae and Dunaliella salina. In figure 31 it 
is shown a detail of the structural model of P. falciparum CA catalytic site. 
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Figure 31. Parcticular of CA catalytic site of Plasmodium falciparum modeled on the 
three-dimensional structure of known CAs. 
 
From that model, it shows that the metal is coordinated with two His residues 
(corresponding to residues 94 and 96 in the sequence of hCA I) and a residue of 
glutamine (which corresponds to residue His119 in sequence hCA I) (Figure 31). 
This coordination pattern was never observed in any of the CAs gene family. It is 
probable that the event, which triggered the separation of η- from α -class, has been 
the mutation of one of the histidine residues that coordinate the zinc ion with the 
residue of glutamine. Moreover, the separation of the class η- from the α-class, is 
also characterized by the replacement of the His residue in position 64 with a 
tyrosine residue (De Simone, G. et al, 2015). 
In collaboration with Prof. Claudiu Supuran, were determined the kinetic 
constants of this new class of CA. PfCA1, showed the following kinetic properties 
for the CO2 hydration reaction to bicarbonate and protons: kcat of 1.4 × 105s-1 and a 
kcat / KM of 5.4 × 106 M-1 × s- 1. In Table XII were compared the kinetic constants of 
PfCA1 with those of other classes of CAs from different organisms. It can be noted 
as PfCA1 presents a significant catalytic action with a kcat of value in the same order 
of magnitude of hCA I and of the CA from Flaveria bidentis, while it is about 28 
times less efficient than the hCA II. Moreover, the activity of PfCA1 is effectively 
inhibited by acetazolamide (KI = 170nM). Although the η- and α-CAs share many 
similar features, strongly suggesting the first ones to be evolutionary derived from 
the last, there are significant differences between the two families to allow some 
optimism for the drug design of selective inhibitors for the parasite over the host 
enzymes. However, these studies are still in their initial phase and further work by X-
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ray crystallography should validate the model proposed in order to detect inhibitors 
with high affinity and selectivity for the η-CAs over the α-CAs 
Table XII. Kinetic parameters for the hydration reaction of CO2 catalyzed by different CA 
belonging to different families. α class : hCA I and II and the bacterial enzyme SazCA 
(Sulfurihydrogenibium azorense). β class :  CH2 (Criptococcus neoformans) and FbiCA1 
(Flaveria bidentis). γ class : is represented by PgiCA (Porphyromonas gingivalis) and that of 
η class from PfCA1 of Plasmodim falciparum. 
 Class Organism kcat  (s-1) kcat/KM (M-1 s-
1) 
KI (nM) 
(acetazolamide) 
hCA I α Mammal 2,0 × 105 5,0 × 107 250  
hCA II α Mammal 1,4 × 106 1,5 × 108 12  
SazCA α Bacteria 4,4 × 106 3,5 × 108 0,9  
Can2 β Fungi 3,9 × 105 4,3 × 107 10,5 
FbiCA1 β Plant 1,2 × 105 7,5 × 106 27  
PgiCA γ Bacteria 4,1 × 105 5,4 × 107 324  
PfCA1 η Protozoan 1,4 × 105 5,4 × 106 170  
 
7.1 η-CA inhibition studies 
The protozoa Trypanosoma cruzi encodes a α-class CA (TcCA) in its 
genome, while Leishmania donovani chagasi, another parasitic protozoa, encodes a 
β-class CA (LdcCA). TcCA is inhibited significantly by sulfonamides, thiols and 
anions, similarly LdcCA is inhibited by sulfonamides and thiols and some of these 
were effective in reduction of the growth of this parasite in vitro. We hypothesize 
that inhibition of protozoan CAs may lead to therapeutic agents that act with a novel 
mechanism of action. To help aid in testing this hypothesis, here we extend our 
knowledge of inhibition of pathogen CAs, specifically targeting the recently char- 
acterized Plasmodium falciparum enzyme PfCA. A selection of representative CA 
inhibitor scaffolds bearing sulfonamides and sulfamate functionality, compounds 1–
24 as well as 15 clinically used or clinically tested agents, were investigated (Figure 
23 of the present thesis). The inhibition data against the human isoforms hCA I and 
hCA II, and protozoan CAs from T. cruzi (TcCA), L. donovani chagasi (LdcCA) and 
P. falciparum (PfCA) with the compounds 1–24 and the 15 clinically used/ tested 
drugs are provided in Table XIII. 
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Table XIII. Inhibition of human isoforms hCA I and hCA II, of the protozoan ones 
from T. cruzi (TcCA), L. donovani chagasi (LdcCA) and P. falciparum η-class 
enzyme (PfCA) with sulfonamides 1–24 and the clinically used drugs AAZ–HCT  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All compounds showed CA inhibitory activity, with multiple inhibitors possessing 
KIs <100 nM identified for the α-class TcCA. and β-class LdcCA, however no 
compound with a KI <100 nM was detected for the η-class PfCA. The best PfCA 
inhibitors were ethoxzolamide EZA and sulthuame SLT, with KIs of 131–132 nM, 
followed by acetazolamide AAZ, methazolamide MZA, and hydrochlorothiazide 
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HCT (KIs ranging from 153 to 198 nM, Table XIII). A striking observation is that 
these CAIs belong to a variety of scaffolds and chemical classes, ranging from 
aromatic primary sulfonamides (SLT), to monocyclic heterocyclic derivatives (AAZ, 
MZA) and bicyclic such derivatives (EZA, HCT). While additional studies are 
required, this observation may provide chemical starting points for development of 
CAIs that target the η-class CAs. Of the remaining clinically used compounds 
brinzolamide BRZ, topiramate TPM, zonisamide ZNS, indisulam IND, valdecoxib 
VLX and celecoxib CLX showed moderate inhibition of PfCA, with KIs ranging 
from 217 to 308 nM. As for the stronger inhibitors, these moderate inhibitors 
similarly comprise heterogeneous structural motifs. The least effective PfCA 
inhibitors from the set of clinically tested compounds were dichlorophenamide DCP, 
dorzolamide DZA, benzola- mide BZA and sulpiride SLP, with KIs ranging from 
542 to 1170 nM (Table XIII). 
Compounds 1–24 are simpler in structure than the clinically tested compounds and 
comprise either the benzene sulfonamide or thiadiazole sulfonamide scaffold 
decorated with small substituents on the aryl/heteroaryl ring or structures with two 
aromatic rings separated by variable spacer groups. Many of these simpler 
compounds showed effective, albeit moderate to weak inhibitory activity of PfCA. 
Compounds 1, 6, 12, 13, 16 and 17 had KIs in the range of 581–758 nM and are 
medium potency PfCA inhibitors. The remaining sulfonamides are weaker inhibitors 
with KIs in the range of 3.65–15.0 µM (Table XIII). In general compounds 1–24 are 
substantially weaker PfCA inhibitors than the clinically used compounds. The 
halogen substitution of the sulfanilamide scaffold 2 (PfCA KI = 5.8 µM) either does 
not improve inhibition or is detrimental to inhibition (compare KI values of 2 with 
halogenated derivatives 7–9, 10 and 12). Secondly, the length of the alkyl spacer 
group present in compounds 5, 6 and 15–17 impacts on the PfCA inhibitory activity, 
inhibition improves from a methylene linker in 5 (PfCA KI = 3.6 µM) and 15 (PfCA 
KI = 4.5 µM) to the ethyl and propyl linkers of 6, 16 and 17 (PfCA KIs  0.7 µM). 
Finally, the sulfanylated sulfanilamides 21– 24 showed very weak PfCA inhibition 
(PfCA KIs 8.4–15.0 µM). 
Considering the small number of inhibition studies reported at this moment 
for the η-CAs, these results demonstrate it is quite probable that effective, low 
nanomolar inhibitors may be developed. Moreover, some dendrimers investigated 
showed a better inhibitory power compared to acetazolamide. The main conclusion is 
that this class of molecules may lead to important developments in the field of anti-
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infective CA inhibitors. Given that drug resistance has emerged against most 
antimalarial in clinical use, the discovery of η-CA -specific inhibitors may lead to a 
novel therapeutic approach for malaria once the biology of η-CA has been further 
investigated in different life cycle stages. 
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Chapter 8.  Malassezia Globosa 
Malassezia yeasts are almost exclusively the single eukaryotic members of the 
microbial flora of the skin. Malassezia have been recognized for more than 150 
years, as members of the human cutaneous flora and etiologic agents of certain skin 
diseases. At the begining of 1800, it was noted that yeast cells and filaments were 
present in the skin scales of patients with pityriasis versicolor, whereas yeast cells, 
but no filaments, were observed in scales from healthy scalp, seborrheic dermatitis 
scalp, and dandruff. Dandruff is a frequent pathological skin condition confined to 
the scalp and is characterized by flaking with minimal to absent inflammation. 
Malassezia genus includes seven species, the three former taxa (M.  furfur, M. 
pachydermatis, and M. sympodialis) and four newtaxa (M. globosa, M. obtusa, M. 
restricta, and M. slooffiae). With the exception of M. pachydermatis, all species 
afore-mentioned require lipids for their growth. Moreover, M. globosa and M. 
restricta are found on the skin of practically all humans. It has been demonstrated 
that oleic acid responsible of the sebum of the scalp is produced from the hydrolysis 
of triglycerides by M. globosa lipases. These data highly implicate M. globosa in the 
pathogenesis of dandruff. Several strategies and treatments are available for 
dandruff, the majority of which aim to target growth of the fungi. A common active 
ingredient in anti-dandruff shampoos is zinc pyrithione, also known as zinc 
pyridinethione A, its effect being most likely mediated through disruption of fungal 
membrane activities. Ketoconazole B, an azole antifungal agent interfering with the 
biosynthesis of fungal sterols is also used in many shampoos. Other azoles have been 
used in anti-dandruff treatments, as they interfere with the synthesis of ergosterol, a 
key component of fungal cell walls. However the effectiveness of A and B for 
preventing/treating dandruff is not very high, and additional therapeutic strategies are 
being explored, such as, for example, inhibition of the lipase present in Malassezia 
spp., or inhibition of the β-carbonic anhydrase (MgCA), which is the single CA-class 
encoded by its genome. Thus, MgCA has been proposed as a novel anti-dandruff 
target. 
 
8.1 Construct preparation, protein expression and purification 
The GeneArt Company, specialized in gene synthesis, designed the synthetic M. 
globosa gene encoding for the β-CA, and containing 4 base pair sequences (CACC) 
necessary for directional cloning at the 5’ end of the MgCA gene. The fragment was 
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subsequently cloned into the expression vector pET100D-Topo (Invitrogen, 
Carlsbad, CA), creating the plasmid pET100D-Topo/MgCA. In order to confirm the 
integrity of the M. globosa gene and the fact that no errors occurred at the ligation 
sites, the vector containing the fragment was sequenced. Competent Escherichia coli 
BL21 (DE3) Codon Plus cells were transformed with pET100/D-Topo/MgCA, 
grown at 37°C, induced with 1mM IPTG. Zn(SO42-) was added after 30 min and 
after additional growth for 3 h, cells were harvested and disrupted by sonication at 
4°C in 20mM buffer phosphate, pH 8.0. Following sonication, the sample was 
centrifuged at 1200g at 4°C for 30 min. The supernatant was dialyzed against 0.02M 
phosphate buffer (pH 8.0) containing 0.01 M imidazole and 0.5M NaCl at 4°C and 
loaded onto a His-select HF Nickel affinity column. The column was equilibrated 
with 0.02M phosphate buffer (pH 8.0) containing 0.01 M imidazole and 0.5M NaCl 
at a flow rate of 1.0 ml/min. The MgCAb was eluted with 0.02M phosphate buffer 
(pH 8.0) containing 0.5 M NaCl and 0.25mM imidazole at a flow rate of 1.0 ml/min. 
Active fractions (1 ml) were collected and combined for a total volume of 5 ml. 
Subsequently, they were dialyzed, concentrated and analyzed by SDS-PAGE. At this 
stage of purification, the enzyme was at least 95% pure (Figure 32). 
 
 
 
Figure 32. SDS-PAGE of the recombinant MgCA purified from E. coli codon plus cells. 
Lane A, molecular markers, M.W starting from the top: 250, 150, 100, 75, 50, 37, 25 and 20; 
Lane B, purified MgCA from Histag affinity column. 
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8.2 Protonography 
Wells of 12% SDS-gel were loaded with bCA and MgCA mixed with loading buffer 
without 2-mercaptoethanol and without boiling the samples, in order to avoid protein 
denaturation. The gel was run at 180V until the dye front ran off the gel. Following 
the electrophoresis, the 12% SDS-gel was subject to protonographyto detect the bCA 
and MgCA hydratase activity on the gel. The analysis by protonography of MgCA 
showed a band of about 29 kDa (monomeric form) under reducing condition (Figure 
33). 
 
 
 
 
Figure 33. MgCA protonogram. The yellow bands correspond to the hydratase activity on 
the gel responsible for the drop of pH from 8.2 to the transition point of the dye. Incubation 
time was of 60 s. bCA is present in the monomeric (29 kDa) form. Lane A, molecular 
markers, M.W. starting from the top: 250, 150, 100, 75, 50, 37, 25 and 20 kDa; Lane B: 
MgCA; Lane C: commercial bovine CA (bCA). 
 
8.3 Kinetic constants 
Using the stopped-flow technique, the kinetic parameters were determined for the 
newly purified recombinant MgCA using CO2 as a substrate. MgCA showed a 
significant catalytic activity, with a kcat of 9.2x105 s-1 and a kcat/Km of 8.3x107 M–
1xs-1. Table XVIII shows a comparison of the kinetic parameters of MgCA with 
those of MG-CA (β-CA cloned as GST-fusion protein), hCA I and II (α-CA from 
Homo sapiens, isoform I and II, respectively) and Can2 (β-CA from C. neoformans). 
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It may be observed that MgCA and MG-CA showed kinetic parameters about 2 times 
higher than the other β-CA reported in Table XIV (Can2), and four times higher than 
the human α-CA isoform I. Moreover, MgCA cloned as Hisfusion protein has kinetic 
data similar to those of the GST-fusion protein reported earlier, but the activity of the 
His-tagged MgCA is better. It is interesting to note that both proteins obtained with 
two different cloning strategies are not affected by acetazolamide inhibition. 
Intriguingly, this lack of effectiveness of AAZ for inhibiting a β-class enzyme has 
been observed only for Cab, an enzyme isolated and characterized from the 
Archaeon Methanobacterium thermoautotrophicum. 
 
Table XIV. Kinetic parameters for the CO2 hydration reaction catalyzed by MG-CA (GST-
fusion protein), MgCA (His-fusion protein), hCA I and II (α-CA from H. sapiens, isoform I 
and II, respectively) and Can2 (β-CA from C. neoformans). 
 
 
 
8.4 Inhibition studies 
Inorganic (complexing) anions represent an interesting class of derivatives, which 
bind metal ions in many types of metalloenzymes. Their chemical simplicity 
represents both a disadvantage as well as an advantage when investigating them as 
CAIs. The disadvantage consists in the fact that due to their propensity to coordinate 
metal ions in solution or in metalloenzyme active sites, usually this class of inhibitors 
is non-selectively binding to many metals present in such enzymes, and furthermore, 
their activities are normally those of weak inhibitors (in the milli-molar, rarely tens 
of micromolar ranges). However, the advantage of this chemical simplicity (but also 
diversity, since a large number of inorganic/organic anions can be envisaged) is 
represented by the fact that many such compounds can be considered as lead 
molecules and further elaborated for leading to highly effective inhibitors. Data of 
Table XV show a very interesting inhibition profile of MgCA with anions and small 
molecules. The following salient features were observed: 
Anions known to possess weak affinity for Zn(II) in other CAs,a such as perchlorate 
and tetrafluoroborate were also not inhibitory against MgCA (as for hCA I and II, the 
two major red blood cell isoforms, which may be considered as the main off targets 
when investigating parasite CAs, like the enzyme considered here). Surprisingly, 
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carbonate, bisulfite and peroxydisulfate showed the same activity, with no inhibition 
of MgCA up to 100 mM concentrations of inhibitor. 
 Some other anions with poor inhibitory properties against MgCA were bromide, 
azide, hydrogen sulfide, perrhenate, and sulfate, diphosphate, divanadate, tetraborate, 
selenocyanide, trithiocarbonate, triflate, hexafluorophosphate, and fluorosulfonate. 
One may see that this is a highly heterogeneous group of anions, incorporating either 
highly simple ones (halides) as well as complex ones, which differ considerably 
in their affinity for metal ions in solutions. Obviously, the environment within the 
active site dramatically interfereswhich had KIs in the range of 11.9–45.2 mM (Table 
XIV). The sulfate data is interesting, as this anion usually has a low affinity for 
Zn(II) in many CAs (e.g., hCA II and I), whereas azide, which is a very weak MgCA 
inhibitor acted as a highly potent one for many α-CAs (e.g., it has a KIs in the 
micromolar rage against hCAI). 
The largest majority of anions investigated here showed a medium potency inhibitory 
power against MgCA with KIs in the low millimolar range (1.73–8.82 mM). Among 
themnare the halides (except bromide), cyanate, thiocyanate, cyanide, nitrate, nitrite, 
stannate, selenate, tellurate, perosmate, with the binding, favoring some and probably 
inducing a less favored binding for other of them, which explains the rather small 
variation in the inhibition constants for this large group of inhibitors. 
A very interesting observation is that among the best anion inhibitors detected here 
were bicarbonate (KI of 0.59 mM) and diethyldithiocarbamate (KI of 0.30 mM).  
It should also be noted the inhibition data between carbonate (not an inhibitor) and 
trithiocarbonate (KI of 1.77 mM) which is one of the efficient inhibitors in the group 
of medium potency anions. 
The best MgCA inhibitors were sulfamide, sulfamate, phenylboronic acid and 
phenylarsonic acid, which had inhibition constants in the range of 83–90 µM 
(comparable with acetazolamide, KI of 74l M, see discussion above). Thus, as for 
other pathogenic enzymes investigated ultimately, this study allowed us to reveal that 
small molecule inhibitors such as dithiocarbamates, sulfamide, sulfamate, 
phenylboronic acid and phenylarsonic acid show an interesting potential for 
designing CAIs with an improved potency.  
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Table XV. Inhibition constants of anion inhibitors against α-CAs from mammals (hCA I, 
and II, human isoforms, and the protozoan enzyme from T. cruzi, TcCA), and the η-CA 
PfCA from P. falciparum, for the CO2 hydration reaction, at 20°C and pH 7.5 
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8.5 Activation studies 
Recently we have extended the CA activation studies to the β-class enzymes from 
pathogenic fungi, such as MgCA. Infact, we report the first activation study of 
MgCA with a series of amines and amino acids (of types 1–19,figure 34.), which 
were investigated earlier for their interactions with mammalian α-CAs as well as 
more recently with the β- and γ-class enzymes from the Archaea domain and from 
pathogenic fungi, respectively. This study may help a better understanding of the β-
CA catalytic/activation mechanism, as the natural proton shuttling residue in this 
class of enzymes has not been yet identified, unlike the α-CAs for which it is known 
that a His residue placed in the middle of the active site cavity (His64, hCA I 
numbering) plays this function. 
 
 
 
Figure 34.  Structure of activators 1–19 investigated in the present study. 
 
Data of Table XVI show that all amino acids and amines 1–19, which have been 
investigated in this study, act as CAAs against the fungal enzyme MgCA. However, 
the activation profiles of these compounds against MgCA are different from other 
recently investigated α- and β-class enzymes, such as hCA II, ScCA and CgCA, 
which were included in Table XVI for comparison. The following structure activity 
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relationship (SAR) can be observed for the activation of MgCA with compounds 1–
19. Several amino acids, such as L-/D-His, L-Phe, D-DOPA, D-Trp, L-/D-Tyr, 4-
amino-L-phenylalanine, as well as serotonin 14, showed activation constants in the 
range of 12.5–29.3 µM, therefore they are considered as moderate MgCA activators. 
However, it may be observed that most of these derivatives (except L-Phe, L-/D-Tyr 
and D-Trp) are much weaker activators of the C. glabrata enzyme CgCA. ScCA on 
the other hand has completely different activation profiles with these derivatives, 
being poorly activated by all amino acids (but slightly more susceptible to activation 
by serotonin). hCA II is highly activated by most amino acids, sometimes with 
activation constants in the nanomolar range11–14 (e.g., L-/D-Phe; L-/D-Tyr). A 
second group of derivatives, including D-Phe, L-DOPA, L-Trp, as well as amines 12, 
13, 15, 16 and 18, acted as more effective MgCA activators when compared to the 
compounds discussed above, with activation constants ranging between 5.82 and 
10.9 µM. Thus, it may be observed that the amines were generally better MgCA 
activators compared to the carboxylic acids with which they are structurally related 
(compare Histamine with L/D-His, or dopamine with L-/D-DOPA, e.g.). The 
heterocylic amines incorporating pyridyl, piperazine, and morpholine rings were 
more effective MgCA activators compared to histamine, dopamine or serotonin. The 
most potent MgCA activators were L-adrenaline 19 and 1-(2-aminoethyl) piperazine 
17, with activation constants of 0.72–0.81 µM. Thus, small structural modifications 
in the scaffold of the amine activator (e.g., compare dopamine 13 with L-adrenaline 
19) lead to drastic changes of the activating effect, with 19 being 13-times a better 
activator compared to 13. 
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Table XVI. Activation constants of hCA II (cytosolic α-isozyme), yeast 
β-CAs from S. cerevisiae (ScCA), C. glabrata (CgCA) and MgCA 
(Malassezia globosa) with amino acids and amines  
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Chapter 9. Evolutionary aspects 
The analysis of the Gram-positive and Gram-negative genomes conducted by 
similarity sequence searching programs, such as Blasta and Fasta, revealed a very 
complex distribution of the different classes of CAs in the two groups of bacteria. In 
fact, the genome of some of them encodes for all three classes of CAs (α, β and γ), 
while for others the genome encodes for two or one classes of CAs. Interestingly, the 
α-CAs are only present in the genome of Gram-negative and not in that of Gram-
positive bacteria. By analyzing these results, in this thesis we will try to answer the 
following questions: 1) Why the α-CA are present only in Gram-negative? 2) What is 
the physiological role of α-CA in bacteria? 3) Why the α-CAs are not present in all 
Gram-negative? 4) Why there are species of bacteria whose genome does not code 
for CA? 
A characteristic common to the α-CA identified in Gram-negative bacteria, it is the 
presence of a signal peptide to the N-terminal of the amino acid sequence (Figure 35 
marked in red). This sequence directs the newly synthesized α-CA towards the 
periplasmic space, i.e. the space between the inner and outer membrane, which is 
absent in Gram-positive bacteria. The presence, then, of the periplasmic space would 
explain why the α-CA are present only in Gram-negative bacteria. 
 
 
 
 
Figure 35. A detail of the multialignment of the α-CA amino acid sequences identified in 
the genome of mammalian and Gram-negative bacteria. The signal sequence included in the 
red rectangle is absent in the two human isoforms hCA I and II, while it is present in the 
mitochondrial form (hCA VA) for localization in the intermembrane space, in the hCA VI 
for secretion in saliva, and in the α- CA for bacterial localization in the periplasmic space.  
 
To understand the role played by α-CA in Gram-negative, need to refer to some 
bacteria characterized by the presence of periplasmic α-CA. Helicobacter pylori is a 
pathogenic bacterium, Gram-negative, flagellated acidophilus, whose natural habitat 
is the gastric mucus of the human stomach. Its genome encodes for a α-, a β- and a γ-
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CA (Nishimori I., et al. 2008; Morishita S., et al. 2008; Chirica L.C., et al. 2002). 
The α-CA has a periplasmic location, the β-CA has a cytoplasmic localization while 
still nothing is known about the expression and localization of γ-CA. H. pylori has 
developed unique adaptive mechanisms for growth in highly acidic environments 
such as the stomach. These mechanisms involve urease and CAs. In acidic 
conditions, urea penetrates into the cell through the channel and urea, in bacterial 
cytoplasm is hydrolyzed to CO2 and 2NH3 (Supuran C.T. 2008) (Figure 36). In the 
bacterial cytoplasm, the CO2 is hydrated by β-CA, while the CO2 diffuses into the 
periplasm is converted to HCO3- by periplasmic α-CA. The ions H+ products are used 
by NH3 to form NH4+ in the periplasm and cytoplasm, respectively. Then, as shown 
in figure 32, the role of periplasmic α-CA and cytoplasmic β-CA it is to produce 
HCO3- and protons to neutralize the acid input. In H. pylori, then, the periplasmic α-
CA is crucial for the acid acclimatization of the pathogen within the stomach. 
(Marcus E.A., et al. 2005; Sachs G., et al. 2005). 
 
Figure 36. Schematization of the role of the α- 
and β-CA in maintaining periplasmic pH in 
Helicobacter pylori. 
 
A similar mechanism has been reported for the Gram-negative bacterium Ralstonia 
eutropha (Gai C.S., et al. 2014). The genome of this bacterium encode for an α-, a β- 
and γ-CA. The α-CA has a periplasmic localization and assists the transport of 
bicarbonate across the cell membrane (Gai C.S., et al. 2014). Concerning the 
bacterium Vibrio cholerae, the α-CA, probably located in the periplasmic space, 
could be involved in the production of bicarbonate, an inducer of gene expression of 
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the virulence of the pathogen. In addition, the two bacteria belonging to the genus 
Sulfurihydrogenibium, S. yellowstonense and S. azorense, which live at temperatures 
up to 110°C, exhibit α-CA characterized by a signal peptide for periplasmic 
localization of this enzyme. These observations allow assuming that in the course of 
evolution, in Gram-negative bacteria, a signal peptide place at the ‘N-terminal of a 
primordial CA, has generated a new class of CAs, namely the α class, with 
localization in the periplasmic compartment. Dr. Clemente Capasso and Prof. 
Claudiu Supuran, have speculated that the α-CA are able to convert the CO2 to 
bicarbonate diffused in the periplasmic space, ensuring the survival and/or satisfying 
the metabolic needs of the microorganism. Instead, the β- and γ-CA localized in the 
cytoplasm are responsible for the supply of CO2 to the carboxylase or for the 
homeostasis of intracellular pH and other functions (Capasso C. & Supuran C.T. 
2014). 
Not all Gram-negative bacteria, however, have α-CAs. Probably the α-CAs are 
not required when the Gram-negative bacteria colonize habitats defined as adverse to 
their survival or limiting for their metabolic needs (Capasso C. & Supran C.T. 2014). 
There are also bacteria whose genome does not code for any class of CAs. A 
very interesting study has shown that knockout mutants for the CAs of Ralstonia 
eutropha, Escherichia coli and Saccharomyces cerevisiae are able to grow only in 
the presence of atmosphere with a CO2 level of between 2 and 5% (Ueda K., et al. 
2012). High levels of CO2, in fact, generate high concentrations of bicarbonate 
spontaneously, through the reaction not catalyzed. These microorganisms lacking the 
CAs, at low concentrations of CO2 (0.035%) are not able to grow, if not by providing 
a sufficient amount of bicarbonate. This shows that the CAs are not necessary for 
microbial growth in environments with high concentrations of CO2 as the intestine, 
the sea water and in conditions of syntrophism and commensalism, but become 
necessary when this gas is present in low concentrations. The bacteria belonging to 
the genera Buchnera and Rickettsia, living in habitats with high concentration of 
CO2, such as soil, seawater or the intestine, do not need CAs. 
We also wondered if there was a relationship between the evolutionary history of 
bacterial CAs and evolution of Gram-positive and Gram-negative bacteria. The 
phylogenetic tree (Figure 37) obtained by aligning the amino acid sequences of the 
α-, β- and γ-CA identified in the genome of Gram-positive and negative bacteria, 
showing that the γ-CA by Gram-positive and negative are closely associated to each 
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other, as meaning that they form mixed groups of γ-CA from Gram-positive and 
Gram-negative bacteria. 
 
 
 
Figure 37. Phylogenetic analysis of α-, β and γ-CA of Gram-positive and negative. For the 
construction of the dendrogram it was used the program PhyML 3.0. 
 
The β-CAs, unlike the γ-CAs, with the exception of LxiCAbeta_+ and 
PgiCAbeta_-, form two separate clusters, one containing the β-CAs only from Gram-
negative bacteria and the other containing β-CAs only from Gram-negative bacteria 
positive. This could be the result of a gene duplication event. The α-CAs, found only 
in Gram-negative bacteria, form a separate cluster, located in the same cluster of β-
CAs of Gram-negative bacteria (Capasso C. & Supuran C.T. 2014). 
The results that come from the phylogenetic analysis is that the ancestral CAs are 
represented by the γ-class. In fact, even if the γ-class is widely distributed in all three 
domains, it is the only mainly identified in archaea, the oldest living organisms on 
our planet (Zimmerman S., et al. 2004; Tripp B.C., et al. 2001 -2004; Smith K.S., et 
al. 1999). 
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This is in agreement with the theory that supports a close relationship 
between the archaea and bacteria Gram-positive and considers phylogenetically 
distinct the Gram-negative bacteria. 
From the γ-class would be originated the β-class of Gram-positive and then that 
of the Gram-negative bacteria. Subsequently, from an ancestral β-CA of a Gram-
negative bacterium, they would originate the α-CAs, the latter exclusively present in 
Gram-negative bacteria. This hypothesis can also be corroborated by the theory of 
“enzyme promiscuity" (Baas B.J., et al. 2013; Chakraborty S., et al. 2013; 
Khersonsky O., et al. 2010), i.e. the ability of an enzyme to catalyze additional 
reactions to the primary role. Tawfick considers, in fact, promiscuity a key factor in 
the evolution of a new function of the same protein (Khersonsky O. & Tawfik D.S. 
2010). In fact, it has been noted that the γ-CAs use only the CO2 as substrate, while 
the β-CAs can hydrolyze in addition to CO2, also hydrogen sulfide and carbonyl 
sulfide. Instead, the αCA not only catalyze the reaction of hydration of CO2 and 
carbon disulphide, but also possess esterase and thioesterasic activity. Furthermore, 
by analyzing the size of the catalytic site bacterial of α-, β- and γ- CAs, it has been 
seen that the catalytic pocket is rather small for the γ-CAs, a bit bigger for β-CAs and 
wide for α-CAs (Figure  38). 
 
Figure 38. Three-dimensional structure of the catalytic site of the γ-(Cam), β-(Can2) 
and α-(hCA II)-CAs. 
Overall, the catalytic efficiency of γ-CA is lower than the β-CA, which in turn 
represent the catalysts less efficient than α-CA (Capasso C. & Supuran C.T. 2014). 
We can conclude that phylogenetic analysis and theory of enzyme promiscuity 
support the hypothesis that the most recent CA is that of α-class (with additional 
catalytic activities), while the γ-CA is the class ancestral, that catalyzes only the 
reaction of hydration of CO2 (with a catalytic efficiency rather low). These results 
are in agreement with the evolutionary theory according to which the Gram-positive 
	 88	
bacteria, characterized by a simple cellular structure, have appeared before the Gram-
negative bacteria with a more complex cell structure (outer membrane and inner 
membrane). 
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Chapter 10. Discussion 
 
Infectious diseases are still today the second leading cause of death worldwide, 
and the abuse and/or inappropriate use of antibiotics have led to a wide spread of the 
phenomenon of the antibiotic resistance of pathogenic microorganisms (Sacarlal J., 
et al. 2009; Nour N.M. 2012). As a general rule antibiotics inhibit the growth of the 
pathogen by acting on metabolic "pathways" such as cell wall biosynthesis, 
biosynthesis of proteins, biosynthesis of DNA and RNA, biosynthesis of folates 
(Gaynor M. & Mankin A.S. 2003). In recent years, many research groups have 
focused their interest of study on CAs of bacteria, fungi and protozoa, since they 
constitute a class of enzymes whose inhibition, as reported in literature, can slow or 
stop the growth of the pathogen through a different mechanism of action respect to 
those reported for antibiotics. CAs are target molecules of many antibacterial or 
antifungal drugs. It has been proved, in fact, that the CA are essential to the life cycle 
of the microorganisms (Capasso C. & Supuran C.T. 2013; Rusconi S., et al. 2004; 
Supuran C.T. 2012). In many pathogenic microorganisms have been identified and 
characterized CAs from at least four gene families α, β, γ and η. Usually bacteria 
encode for CA belonging to the classes α, β and γ. It has been reported in literature 
that the in vivo inhibition with sulfonamides and phenolic derivatives of the bacterial 
CAs identified in Helicobacter pylori, Mycobacterium tuberculosis and Brucella 
suis, hindered the growth of microorganisms. The acetazolamide and ethoxzolamide 
have been used in the clinic in the 80th and 90th as anti-ulcer agents and has been 
shown that the inhibition of CA from Helicobacter pylori represented a valid 
alternative for the control of the disease. The crystallographic structure of 
Helicobacter pylori α-CA complexed to acetazolamide or methazolamide represents 
a useful template for designing highly selective inhibitors for the bacterial CAs with 
few side effects. Fungi express α- and β-CA and it was found that the inhibition of 
these enzymes with sulfonamides, thiols and dithiocarbamates, block the in vivo 
growth of Malassezia globosa, Candida albicans and Crytpococcus neoformans. 
Protozoa, however, encode for α- β- or η-CA. It has been shown that sulphonamidic 
inhibitors, thiols and idroxamates actually cause the death of some microorganisms 
in vivo such as Trypanosoma cruzi, Leishmania donovani chagasi and Plasmodium 
falciparum.  
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Vibrio cholerae CAs 
In the present thesis it has been shown that the sulfonamides and their relative 
bioisosteres and, anions inhibited in vitro the three classes of CAs identified in the 
genome of Vibrio cholerae, indicated with the acronyms VchCA (α), VchCAβ (β) 
and VchCAγ (γ). The three enzymes are efficient catalysts for CO2 hydration, with 
kcat values ranging between (3.4 − 8.23) × 105 s−1 and kcat/KM of (4.1 − 7.0) × 107 
M−1 s−1. We also compared the thermostability of three CAs from the bacterial 
pathogen Vibrio cholera. The results demonstrated that VchCA (α-CA) was more 
stable with respect to the β and γ-CAs identified in the genome of V. cholerae. The 
inhibition study with a panel of sulfonamides and one sulfamate led to the detection 
of a large number of nanomolar VchCA, VchCAβ and VchCAγ inhibitors, including 
simple aromatic/heterocyclic sulfonamides (compounds 2-9, 11, 13-15, 24) as well as 
EZA, DZA, BRZ, BZA, TPM, ZNS, SLP, IND (KIS in the range of 66.2-95.3 nM). 
A set of inorganic anions and small molecules was investigated for inhibition of 
these enzymes. Perchlorate and tetrafluoroborate were not active inhibitors (KIs > 
200 mM), whereas sulfate was a moderate inhibitor of VchCA and VchCAγ (KIs of 
0.85–9.65 mM). The most potent VchCAγ inhibitors were N,N-
diethyldithiocarbamate, sulfamate, sulfamide, phenylboronic acid and phenylarsonic 
acid, with KI values in a range from 44 to 91 µM. The most active VchCA inhibitors 
were hydrogensulfite, bisulfite, trithiocarbonate, N,N-diethyldithiocarbamate, 
sulfamide, sulfamate, phenylboronic acid and phenylarsonic acid, with KI values 
between 8 and 88 µM; while the most effective VchCAβ inhibitors were sulfamide, 
sulfamate, phenylboronic acid and phenylarsonic acid, with KI values between 54 
and 86 µM. As it was proven that bicarbonate is a virulence factor of this bacterium 
and since ethoxzolamide was shown to inhibit this virulence in vivo, we propose that 
VchCA, VchCAβ and VchCAγ may be a target for antibiotic development, 
exploiting a mechanism of action rarely considered up until now, i.e., interference 
with bicarbonate supply as a virulence factor. The inhibition profile of VchCA, 
VchCAβ or VchCAγ was different from that of the other bacterial or mammalian 
CAs investigated up until now, proving that probably it will be possible to design 
VchCA, VchCAβ or VchCAγ selective inhibitors using the scaffold of leads detected 
here.  
Moreover, the X-ray crystal structure of the VchCAβ was solved at 1.9Å 
resolution from a crystal that was perfectly merohedrally twinned, revealing a 
tetrameric type II β-CA with a closed active site in which the zinc is tetrahedrally 
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coordinated to Cys42, Asp44, His98 and Cys101. The substrate bicarbonate was 
found bound in a noncatalytic binding pocket close to the zinc ion, as reported for a 
few other β-CAs, such as those from Escherichia coli and Haemophilus influenzae. 
 
Porhyromonas gingivalis CAs 
The oral pathogenic bacterium Porphyromonas gingivalis, the main causative 
agent of periodontitis, encodes for two CAs one belonging to the β-class (PgiCAb) 
and another one to the γ-class (PgiCA). These bacterial CAs, produced as 
recombinant enzyme, showed a good catalytic activity for the CO2 hydration 
reaction, comparable to that of the human isoform hCA I. PgiCA has been 
characterized for its inhibition profile with various classes of CA inhibitors, such as 
the sulfonamides and anions, whereas PgiCAb has been analyzed only for the anion 
inhibition profile. The PgiCA inhibition profile obtained using a wide range of 
pharmalogical and not-pharmacological sulfonamides was very different when 
compared with that obtained for the human isoenzymes, hCAI and II, CAM and the 
β-CA from a protozoan parasite. Dichlorophenamide, topiramate and many simple 
aromatic/heterocyclic sulfonamides were ineffective as PgiCA inhibitors whereas the 
best inhibition was observed with halogenosulfanilamides incorporating heavy 
halogens, 4-hydroxy- and 4-hydroxyalkyl-benzenesulfonamides, acetazolamide, 
methazolamide, zonisamide, indisulam, celecoxib, saccharin and hydrochlorothiazide 
(KIs in the range of 131–380 nM). Inorganic anions such as thiocyanate, cyanide, 
azide, hydrogen sulfide, sulfamate and trithiocarbonate were effective PgiCA 
inhibitors with inhibition constants in the range of 41–97 µM. Other effective 
inhibitors were diethyldithiocarbamate, sulfamide, and phenylboronic acid, with KIs 
of 4.0–9.8 µM.  PgiCAb has a good catalytic activity for the CO2 hydration reaction, 
with kcat 2.8×105 s-1 and kcat/Km of 1.5×107 M-1 s-1, being inhibited by cyanate and 
diethyldithiocarbamate in the submillimolar range (KIs of 0.23-0.76 mM) and more 
efficiently by sulfamide, sulfamate, phenylboronic acid and phenylarsonic acid (KIs 
of 60-78 µM). 
The role of these enzymes as a possible virulence factor of P. gingivalis is poorly 
understood at the moment but its good catalytic activity and the possibility to be 
inhibited by a large number of compounds may led to interesting developments in the 
field. The anion inhibition profile of the two P. gingivalis enzymes is very different. 
Identification of selective inhibitors of PgiCAb/PgiCA may lead to pharmacological 
tools useful for understanding the physiological role(s) of these enzymes, since this 
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bacterium is the main causative agent of periodontitis and few treatment options are 
presently available. 
 
Plasmodium falciparum CA 
For the treatment of diseases such as malaria, for example, several drugs are 
available, but over the years, their effectiveness is greatly diminished and, thus, 
remains the problem of antibiotic resistance. Protozoa, such as Plasmodium 
falciparum, utilize purines and pyrimidines for DNA/RNA synthesis during its 
exponential growth and replication. Plasmodia synthesize pyrimidines de novo from 
HCO3-, which is the substrate of the first enzyme involved in the Plasmodia 
pyrimidine pathway. HCO3- is generated from CO2 through the action of a CA. Our 
studies have shown that PfCA, the CA identified in the genome of Plasmodium 
falciparum, belongs to a new class of CAs, called η. The metal ion coordination 
pattern of the η-CA from the malaria producing protozoa P. falciparum is unique 
among all seven genetic families encoding for such enzymes, comprising two His 
and one Gln residues, in addition to the water molecule/hydroxide ion acting as 
nucleophile in the catalytic cycle. The inhibition study of the η-CA against a panel of 
sulfonamides and one sulfamate compound, some of which are clinically used, 
showed that the strongest inhibitors identified were ethoxzolamide and sulthiame, 
with KIs of 131-132 nM, followed by acetazolamide, methazolamide and 
hydrochlorothiazide (KIs of 153-198 nM). Brinzolamide, topiramate, zonisamide, 
indisulam, valdecoxib and celecoxib also showed significant inhibitory action against 
PfCA, with KIs ranging from 217 to 308 nM. An interesting observation was that the 
more efficient PfCA inhibitors are representative of several scaffolds and chemical 
classes, including benzene sulfonamides, monocyclic/bicyclic heterocyclic 
sulfonamides and compounds with a more complex scaffold (i.e., the sugar sulfamate 
derivative, topiramate, and the coxibs, celecoxib and valdecoxib). This study 
provides a platform for the development of next generation novel PfCA inhibitors. In 
fact, the inhibition of the CA of pathogenic microorganisms such as bacteria, 
protozoa and fungi, can represent an alternative approach for the design of 
antibacterial/pesticides/antifungal with a novel mechanism of action. α-CAs are 
potential drug targets, as shown by the use of sulfonamides in the clinic for the 
treatment of infection by Helicobacter pylori (Puscas I. 1984) and for the β-, γ- or η-
class CAs there is a great interest in identifying selective inhibitors, since they are 
absent in humans and other mammals.  
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Malassezia globosa CA 
Malassezia globosa is highly implicated in the pathogenesis of dandruff and its 
genome encodes for only one carbonic anhydrases belonging to the β-class (MgCA). 
In the past, MgCA was cloned as GST-fusion protein, but the yield was rather low 
and the protein was often found in inclusion bodies. Here, we cloned the recombinant 
MgCA as His-Tag fusion protein. This procedure resulted in a good method to 
express and purify the active recombinant MgCA, and the protein recovery was 
better with respect to that used for preparing MG-CA (β-CA cloned as GST-fusion 
protein). Here, it has been reported an extensive anion inhibition study. It was 
demonstrated that metal complexing anions such as cyanate, thiocyanate, cyanide, 
azide are weak MgCA inhibitors (KIs ranging between 6.81 and 45.2 mM), whereas 
bicarbonate (KIs of 0.59 mM) and diethyldithiocarbamate (KIs of 0.30 mM) together 
with sulfamide, sulfamate, phenylboronic acid and phenylarsonic acid were the most 
effective inhibitors detected (KIs ranging between 83 and 94 µM). Carbonate, similar 
to perchlorate or tetrafluoroborate, did not inhibit MgCA up to 100 mM. This study 
allowed a deep understanding of inhibition mechanisms with these classes of 
compounds and led to interesting drug design campaigns and the discovery of CAIs 
with a good selectivity ratio for inhibiting enzyme classes or isoforms of medicinal 
interest. 
 
Phylogenetic analysis 
The complex distribution of the various CA classes in Gram-positive and negative 
bacteria allowed us to find a correlation between the evolutionary history of the 
bacteria and the three CA classes (α, β and γ) identified in their genome. Prokaryotes 
appeared on the Earth 3.5-3.8 billion years ago, while eukaryotes were dated 1.8 
billion years ago. During the first 2.0-2.5 billion years the Earth's atmosphere not 
contained oxygen, thus the first organisms were anaerobic. Eukaryotic organisms 
almost aerobes developed on the Earth when the atmosphere was characterized by 
stable and relatively high oxygen content. All the oldest part of the evolutionary 
history of the planet and more than 90% of the phylogenetic diversity of life can be 
attributed to the microbial world. Moreover, the fact that the archaea are distinct 
from other prokaryotes is demonstrated by the existence of protein sequences that are 
present in archaea, but not in eubacteria (Gupta R.S. 1998). Many phylogenetic 
methods support a close correlation of archaea with Gram-positive bacteria, while 
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Gram-negative bacteria form a separate clade, indicating their phylogenetic 
distinction. Gupta et al. believe that the Gram-positive bacteria occupy an 
intermediate position between archaea and Gram-negative bacteria, and that they 
evolved precisely from archaea. Phylogenetic analysis of carbonic anhydrases 
identified in bacteria Gram-positive and negative, showed that the ancestral CA is 
represented by γ-class. In, fact, the γ-CA is the only CA class, which has been 
identified in archaea (Zimmerman S., et al. 2004; Tripp B.C., et al. 2001-2004; 
Smith K.S., et al. 1999). This is consistent with the theory that maintains a close 
relationship between the archaea and the Gram-positive bacteria, considering Gram-
negative arising from the latter. Furthermore, phylogenetic analysis of bacterial CAs 
showed that the α-CAs, exclusively present in Gram-negative bacteria, were the most 
recent CAs. These results have been corroborated by the enzymatic promiscuity 
theory, which is the ability of an enzyme to catalyze a side reaction in addition to 
main reaction (Torrance J.W., et al. 2007). In fact, as described in the Results 
section, the α-CAs can catalyze secondary reaction, such as the hydrolysis of p-NpA 
or thioester, in addition to its primary reaction consisting in the CO2 hydration. 
 
Protonography 
Protonography is a new technique, which allows the detection of carbonic 
anhydrases activity on a SDS polyacrylamide gel. The name ‘‘protonography’’ was 
chosen because CA activity produces hydrogen ions (protons) during the catalyzed 
reaction. These protons are responsible of the change of color that appears on the gel, 
in correspondence of the CO2 hydrase activity. The advantage of this technique is 
that on the basis of molecular weight markers, recombinant or native CAs with 
different molecular weights can be detected and quantified rapidly on a single gel. 
Another improvement of this technique is the possibility to reveal CAs in biological 
systems, such as tissues or bacterial extracts from which only the genome 
information is so far available. In this case, protonography might be the method of 
choice for CAs screening, identification and characterization. Furthermore, 
protonography coupled with mass spectrometry for protein identification will make 
possible the broader mapping of active CAs present in protein extract from various 
sources, allowing the detection of distinct CA isoforms. 
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Chapter 11. Conclusions 
My PhD project brought new insights in the field of carbonic anhydrases. It has 
been demonstrated: a) the studies carried out on the CAs from pathogens have 
identified selective inhibitors to be used as anti-infective; b) the discovery of the η-
CA, a new genetic families of CAs; c) the introduction of a new technique, named 
protonography, useful for the identification of CA activity on a polyacrylamide gel; 
and d) it was speculated on the evolution of the CA classes (α, β and γ) identified in 
the Gram-negative and -positive bacteria. Our main hypothesis is that from the 
ancestral sequence of CA, the γ-class arose first, followed by the β-class; the α-class 
CAs came last and it is found only in the Gram-negative bacteria. 
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